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The bacterium Vibrio cholerae is the causative agent of the acute diarrhoeal disease 
cholera. V. cholerae is naturally found in aquatic environments, where it attaches to 
chitinous surfaces for survival, but can switch lifestyles to cause disease in humans. The 
switch in lifestyle requires modulation of genetic systems and much of the regulation 
occurs at the level of gene expression and is controlled by transcription factors. In this 
work, I show that the global transcription regulator, cAMP receptor protein (CRP), plays 
an integral role in the regulatory network that controls lifestyle switching. I have 
identified two sites for CRP in the intergenic region between rtxHCA and rtxBDE, a locus 
which encodes the multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin and 
toxin transport system respectively. Using a combination of genetics, biochemistry and 
in vivo animal studies, I have determined a CRP dependent regulation of gene expression 
for toxin transport in response to infection of the host. This work shows that rtxHCA is 
constitutively expressed and not subject to regulation by CRP whist CRP acts as a 
repressor of rtxBDE transcription. Examination of further CRP targeted genes reveals a 
similar behaviour upon host colonisation. These findings suggest that toxin export occurs 
in nutritionally rich environments such as the intestines, where the MARTX toxin can 
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1.1 Bacterial gene expression and regulation 
Bacterial cells use intricate molecular processes to regulate the activity of genes and 
proteins (Watson, 2014). These processes allow bacteria to respond to their varied 
environments (Watson, 2014). Hence, transcriptional control determines which 
messenger RNA (mRNA) is transcribed from the DNA template and translational control 
which mRNA molecules are translated to make polypeptides (Figure 1.1) 
1.2 Transcription by RNA polymerase 
RNA polymerase (RNAP) catalyses the synthesis of RNA using the DNA as a template 
in a process called transcription. This is the first step of gene expression and is carefully 
regulated. The RNAP core enzyme is approximately 400 kDa and is made up of multiple 
subunits (Browning and Busby, 2016). Hence, there are two copies of the α subunit and 
one each of β, β’ and ω subunits, arranged in a ‘crab-claw’ structure (Browning and 
Busby, 2016). Alone, the RNAP core enzyme is capable of catalysing transcription of 
RNA non-specifically (Yang and Lewis, 2010). A high resolution structure of the RNAP, 
and a simplified schematic, is shown in Figure 1.2. For specific transcription of genes to 
occur, RNAP must recognise defined sites on the DNA strand (Feklistov, 2013; Lee et 
al., 2012). To do this, the core enzyme associates with a specialised DNA binding protein 














Figure 1.1. Bacterial gene expression 
Schematic diagram of bacterial gene expression. The DNA helix is shown in black. The 
rungs represent nucleotide base pairs and the rails represent the sugar phosphate 
backbone. The 5’ and 3’ notations represent carbons attached to the phosphate and 
hydroxyl groups of the backbone respectively. DNA serves as the template from which 
mRNA is synthesised (transcription). The resulting mRNA molecules, shown in purple, 
provide the template from which polypeptides are synthesised (translation). The protein 
chain and the amino acids that make up the polypeptide chain are shown as blue circles. 





























Figure 1.2. RNA Polymerase holoenzyme 
A) Crystal structure of E. coli RNAP holoenzyme. The subunits are colour coded and the 
Mg2+ is shown in yellow. Image is based on Murakami (2013), and was generated 
using PyMOL (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, 
LLC.) Protein data bank accession number 4YG2(Murakami, 2013). 
B) Schematic diagram of the RNA polymerase holoenzyme. The β and β’ subunits are 
shown in blue and purple respectively. The αCTD and αNTD domains are shown in 
brown and the sigma factor (σ) is shown in grey. The ω subunit is shown in red and 











This form of RNAP (the holoenzyme) is able to recognise specific DNA sequences called 
promoters, thereby transcription initiates at defined sites (Feklistov, 2013). Many 
regulatory steps occur at the transcription initiation stage and determine whether a gene 
will be transcribed or not (Browning and Busby, 2016). 
 
1.3 Promoters  
Promoters are regions of DNA that stimulate transcription and are found upstream of 
genes (Bae et al., 2015). Housekeeping promoters typically contain two conserved 
regions of six nucleotides. These are called the -10 and -35 elements and are separated by 
16-19 nucleotides (Estrem et al., 1999; Yang and Lewis, 2010; Shimada et al., 2014; Ruff 
et al., 2015). The -10 element (TATAAT) and the -35 element (TTGACA) together 
comprise the core promoter (Feklistov, 2013). Most bacteria have one major 
housekeeping σ factor. In Escherichia coli this is referred to as σ70 and is responsible for 
initiating transcription from thousands of promoters during exponential growth (Shimada 
et al., 2014). The sequence of promoters usually differs from the consensus and correlates 
with basal promoter activity (Shimada et al., 2014). Hence, promoters can either be weak 
(poor sequence similarity to consensus) or strong (high sequence similarity to consensus) 
drivers of transcription. Promoter strength is also defined by the presence of additional 
DNA elements that enhance the binding of RNAP (Browning and Busby, 2004). Such 
elements include the extended -10 element (a TGn motif upstream of a standard -10) and 
UP element (Figure 1.3). These provide additional contacts for RNAP (Ross et al., 1993; 





Figure 1.3. Bacterial Promoter 
Schematic diagram of a bacterial promoter. The black arrow labelled +1 denotes the 
transcription start site. The -10, extended -10 and -35 motifs are recognised by σ (grey), 
and the UP element is recognised by αCTD (brown circles) subunit of RNAP. The omega 
subunit is shown as a red circle and the Mg2+ catalytic site is represented by a yellow 











The process of transcription can be divided into several stages; initiation, elongation and 
termination (Yang and Lewis, 2010). The first step in initiation is the binding of RNAP 
holoenzyme to the promoter DNA as illustrated in Figure 1.4 (Browning and Busby, 2016; 
Murakami and Darst, 2003). Two models exist to describe this step. The first school of 
thought is that RNAP recognises the -10 element in double stranded form as a closed 
complex (Zuo and Steitz, 2015). Subsequently, it is suggested that both RNAP and the 
promoter DNA undergo conformational changes (isomerisation) that result in the 
separation of the two DNA strands, to form an open complex (Zuo and Steitz, 2015). 
Conversely, Feklistov and colleagues offer an alternative to the formation of a closed 
complex (Feklistov and Darst, 2011). Instead, they propose that recognition of the -10 
element is coupled with DNA strand separation and comes into play only in the open 
complex. Hence, x-ray crystal structures show that specific bases of the promoter are 
captured by σ70 pockets, only in the context of the open promoter complex (Feklistov and 
Darst, 2011; Bae et al., 2015). In both models, the open complex contains DNA denatured 
between positions -11 upstream and +3 downstream of the transcription start site (Yang 
and Lewis, 2010; Bae et al., 2015; Browning and Busby, 2004; Tsujikawa et al., 2002). 
In this conformation an uptake channel, made of regions from the RNAP β and β’ 
subunits, is formed (Zuo and Steitz, 2015). The channel allows ribonucleotides to enter 
the enzyme and assemble in the active site to create a new mRNA chain (Goldman et al., 


















Schematic of transcription initiation at promoter DNA. Transcription initiation occurs 
when RNAP binds to promoter DNA (promoter recognition) to form the closed complex 
(RPc). Approximately 12 bp of promoter DNA is unwound (isomerisation) to form a 
transcription bubble to generate an open complex (RPo). A channel is formed which 
enables the uptake of NTPs into the active site of RNAP to assemble mRNA. During 
several attempts to escape the promoter, abortive transcripts are generated (abortive 
RNAs). However, once more than 10 bps are transcribed, RNAP unbinds the promoter 





































(Marchetti et al., 2017; Zhang et al., 2012). The omega subunit is shown as a red circle 




The assembly of the new mRNA chain begins with “scrunching”, whereby RNAP 
remains fixed on the promoter DNA and pulls the downstream DNA towards itself 
(Kapanidis et al., 2006). This typically leads to synthesis and release of short transcripts 
of mRNA (Kapanidis et al., 2006). Once the nascent mRNA chain reaches ten 
ribonucleotides long, the enzyme undergoes promoter escape and moves into the 
elongation phase of transcription (Marchetti et al., 2017). Elongation continues until 
RNAP reaches a pause, or terminator (Marchetti et al., 2017).  Termination allows 
accurate expression of genes by preventing the inappropriate transcription of adjacent 
genes. The process also ensures that RNAP is removed from the end of transcripts and 
recycled for use elsewhere on the chromosome (Peters et al., 2011; Ray-Soni et al., 2016). 
Bacteria utilise two main mechanisms for transcript termination; intrinsic termination and 
Rho-dependent termination (Ray-Soni et al., 2016). 
Intrinsic termination, also called Rho-independent termination, occurs when RNAP 
encounters a terminator sequence (Peters et al., 2011). Terminator sequences are often 
found at the end of genes and are characterised by GC rich repeats followed by a stretch 
of Ts (Peters et al., 2011). When transcribed, terminators create stem-loop structures, 
called terminator hairpins, RNA in molecules. These structures disrupt the elongation 
complex and the nascent RNA chain dissociates from RNAP (Peters et al., 2011; Ray-
Soni et al., 2016).  
In Rho-dependent termination, an auxiliary protein called Rho, an RNA-dependent 
ATPase, is required for termination (Banerjee et al., 2006). Rho binds to the nascent RNA 
and translocates along the mRNA chain until it encounters the elongation complex and 
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causes the dissociation of RNAP from the DNA (Banerjee et al., 2006; Grylak-Mielnicka 
et al., 2016). In contrast to intrinsic terminators, natural Rho utilisation (rut) sites are less-
specific and contain few common features apart from high C content sequences (Peters 
et al., 2011).  
 
1.4 Transcriptional Regulation 
In bacteria, control of gene expression often responds to extracellular signals (Browning 
and Busby, 2004; Marchetti et al., 2017). These signals lead to the regulation of target 
genes by regulatory proteins such as transcription factors (TF) (Browning and Busby, 
2004; Lee et al., 2012). These proteins can positively regulate gene transcription 
(activators) or negatively regulate transcription (repressors) (Browning and Busby, 2004). 
Since RNAP binds weakly at many promoters (Lee et al., 2012) transcription initiation 
can be enhanced by the direct or indirect effect of activators on RNAP (Browning and 
Busby, 2004). Hence, activators often bind in the proximity of promoters to enhance 
transcription (Browning and Busby, 2004; Martı́nez-Antonio and Collado-Vides, 2003). 
One such transcription factor is a global regulator called cyclic AMP receptor protein 
(CRP). E. coli encodes seven global regulatory proteins that directly and indirectly 
modulate 50% of all genes in E. coli (Martı́nez-Antonio and Collado-Vides, 2003). The 
widely accepted role of CRP is as the main regulator of catabolism in enteric bacteria 
(Shimada et al., 2011). In E. coli, CRP controls carbon metabolism by regulating the 
12 
 
transcription of genes that facilitate the use of alternate carbon sources in a regulatory 
process called catabolite repression (Botsford and Harman, 1992).  
In addition to its role in catabolite repression, CRP also regulates the expression of genes 
involved in pathogenicity and processes not related to metabolism (Botsford and Harman, 
1992; Skorupski and Taylor, 1997a; Chattopadhyay and Parrack, 2006; Zahid et al., 
2015). Usually, CRP activates transcription by binding upstream of, or adjacent to, the -35 
promoter element. Depending on the position of the CRP site, promoters are called Class 





1.5 Transcription regulation by CRP  
The E. coli CRP binds as a 45 kDa dimer and is composed of two identical 209 amino 
acid subunits (Kolb et al., 1993). The protein shares structural properties with CRP from 
other enteric bacteria, suggesting a similar role in different species (Chattopadhyay and 
Parrack, 2006). Each CRP subunit consists of a DNA binding domain and a dimerization 
domain that interacts with the effector molecule cAMP (Figure 1.5) (de Crombrugghe et 
al., 1984). The C-terminal domain (CTD) of CRP binds DNA upstream of promoters at 
a 22 base pair (bp) sequence 5’AAATGTGATCTAGATCACATTT 3’ containing an 
inverted repeat motif (in bold) (Shimada et al., 2011). In the absence of cAMP, CRP can 
be found in free solution or weakly bound to DNA (Chattopadhyay and Parrack, 2006; 
Kolb et al., 1993). When bound to its allosteric effector molecule, cAMP, CRP undergoes 
conformational changes that increase sequence-specific binding to DNA (de 
Crombrugghe et al., 1984; Botsford and Harman, 1992). In E. coli, CRP directly regulates 
transcription from more than 100 promoters by either interacting with RNAP directly 
(activation), or by blocking promoter access (repression) (Busby and Ebright, 1999; 
Müller-Hill, 1998; Kolb et al., 1993). Transcription activation at CRP-dependent 
promoters often involves a direct contact between RNAP and surface exposed regions on 
CRP called activating regions (Williams et al., 1996). These regions are involved in direct 







Figure 1.5. Crystal structure of CRP cAMP and DNA complex 
Crystal structure of CRP subunits bound to DNA. CRP subunits shown in orange, contain 
cAMP molecules (yellow) bound within the dimerization N-terminal domain. Activating 
regions 1 (blue), 2 (cyan) and 3 (magenta) make direct contact with RNAP to activate 
transcription at certain promoters. DNA (shown in black) is bound by the residues (shown 
in green) within the C-terminal domain. Image was generated using PyMOL (Liu et al., 








1.6 CRP activated Promoters 
1.6.1 Class I promoters 
At class I promoters, CRP binds to DNA sites upstream of the -35 promoter element 
(Browning and Busby, 2016; Lawson et al., 2004). CRP recruits RNAP using a single 
interaction requiring residues 156-164 of activating region 1(AR1) and the 287 
determinant of the RNAP αCTD (Figure 1.6) (Browning and Busby, 2004; Browning and 
Busby, 2016; Savery et al., 1998; Liu et al., 2017; Savery et al., 2002). Due to its ability 
to bend DNA, CRP binding sites can be found at various distances upstream of the 
transcription start site centred close to positions -61, -71, -82 or -93 (Lawson et al., 2004; 
Zhou et al., 2014). Hence, in order to activate transcription, CRP and RNAP must be 
bound on the same face of the DNA helix (Ebright, 1993; Zhou et al., 2014). The best 
known example of class I activation is the E. coli lac promoter (Figure 1.6a), where CRP 
binds at position -61.5 (Ebright, 1993; Estrem et al., 1999; Lawson et al., 2004). 
1.6.2 Class II promoters 
At class II promoters, CRP binds near to position -41, overlapping the -35 promoter 
element (Busby and Ebright, 1997). As a result, CRP makes three interactions with RNAP 
to activate transcription; AR1 contacts the αCTD, AR2 the αNTD and AR3 contacts 
region 4 of the σ subunit (Browning and Busby, 2004; Savery et al., 1998; Savery et al., 
1996; Rhodius and Busby, 2000). Seven residues (R265, K271, T285, E286, V287, E288 
and R317) identified within the RNAP αCTD were important for the activation of 
transcription by CRP (Savery et al., 1998). Residues T285, E286, V287, E288 and R317 
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were determined to be required to form interactions between CRP and RNAP αCTD but 
not required for RNAP αCTD- DNA interactions (Savery et al., 1998). Examples of class 
II promoters are the E. coli galP1 and melR promoters (Figure 1.6b) that have a CRP site 
at position -41.5 (Busby and Ebright, 1999; Lawson et al., 2004). 
1.6.3 Class III promoters 
Class III promoters have a more complex architecture (Browning and Busby, 2004). 
Unlike class I and class II promoters, which contain only one CRP site, class III promoters 
often contain multiple CRP sites at varying distances between each other and the RNAP 
binding site (Ebright, 1993). Class III promoters usually require multiple RNAP contacts 
(Figure 1.6c), that activate transcription through a combination of class I and class II 
mechanisms (Busby and Ebright, 1999). At some class III promoters, CRP interacts with 
other activators to synergistically enhance transcription (Busby and Ebright, 1999). These 
interactions can either be independent, whereby CRP and the second activator each make 
seperate contacts with different surfaces of RNAP; or direct, in which CRP forms protein-
protein interactions with another activator to allow interaction of RNAP with the -35 













Schematic of transcription activation at class I, II and III promoters.   
A) At class I promoters, CRP (orange) binds as a dimer upstream of the promoter -35 
element and interacts with the αCTD of RNAP to activate transcription.  
B) At class II promoters the CRP binding site is adjacent to or overlaps the promoter -35 
element. This leads to multiple interactions between CRP and RNAP. One copy of the 
αNTD interacts with activating region (AR) 2 of CRP and another interaction is made 
between αCTD and AR1 of CRP.  


































C) Class III promoters, multiple dimers of CRP act in synergy to activate transcription. 
Multiple interactions are made with RNAP in a combination of both class I and class II 
mechanisms. (Browning and Busby, 2004; Busby and Ebright, 1999).
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1.7 Repression by transcription factors and nucleoid associated 
proteins 
Repressor proteins also control transcription by binding to promoters. However, repressor 
binding seems to reduce or prevent RNAP binding or other steps in transcription initiation 
(Browning and Busby, 2004). Repression can result from interference with RNAP 
directly or via an activator (Browning and Busby, 2016). As reviewed by Browning and 
Busby (2004), there are three general mechanisms of repression; steric hindrance, 
repression by looping and repression by modulation of the activator (Figure 1.7). 
1.7.1 Repression by steric hindrance 
In repression by steric hindrance, the repressor binds close to, or overlapping, the core 
promoter elements (Figure 1.7a). Binding of the repressor protein may interfere with the 
recruitment of RNAP. This is exemplified by binding of the LexA repressor at the uvrA 
promoter and the Lac repressor to the lac operator region of the lac promoter (Browning 
and Busby, 2004; Rojo, 1999).  
1.7.2 Repression by looping 
This type of repression is caused by the interaction of distal DNA sites through the 
binding of multiple repressors (Figure 1.7b). An example of this type of repression is seen 
at the gal promoter that is repressed by GalR (Choy and Adhya, 1992). Interactions 
between repressors bound at distal promoter sites may lead to the looping of the DNA 
around the core promoter elements. This either prevents the recruitment of RNAP or traps 
RNAP at the promoter (Browning and Busby, 2004). 
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1.7.3 Repression by modulation of an activator 
Here, the repressor interacts with the activator protein and hinders its interaction with 
RNAP. A classic example of such repression is the interaction between CytR and CRP at 
certain CRP controlled promoters (Figure 1.7c). The CytR repressor binds between two 
CRP dimers and shields the activating region of the activator from RNAP (Müller-Hill, 
1998; Valentin-Hansen et al., 1996; Browning and Busby, 2004). 
 
1.7.4 Repression by multiple CRP sites 
This type of repression is found at some promoters carrying tandem DNA sites for CRP 
(Lee and Busby, 2012). At these sites, the distance  between the promoter and the CRP 
binding site determines whether promoter activity was upregulated or downregulated 
(Tebbutt et al., 2002). Repression at these promoters was determined by the upstream 
CRP dimer which, when bound at position -122.5, interacts with the αCTD of RNAP 


















Figure 1.7. Repression mechanisms at promoters 
Schematic diagram showing repression at bacterial promoters by transcription factors. 
A) In repression by steric hindrance the repressor binds within the promoter elements, 
therefore competing with and excluding RNAP from its binding site.  
B)  Repression by looping occurs when repressors bind to different sites along the 
DNA and interact with each other. The interaction leads to the looping of DNA 
































C) Repression by modulation of activator occurs when the repressor interacts to stop 
transcription activators functioning. In this case CRP (orange), is prevented from 




1.8 Transcriptional regulation by the histone-like nucleoid 
structuring protein  
The histone-like nucleoid structuring protein (H-NS) is a nucleoid associated protein and 
repressor of transcription (Wang et al., 2015). H-NS is an abundant nucleic acid binding 
protein with high affinity for AT-rich, curved DNA (Ayala et al., 2017). The H-NS 
protein modulates gene expression by binding to, and silencing, horizontally acquired 
genes (Atlung and Ingmer, 1997; van der Valk et al., 2017; Dorman, 2013). H-NS is a 
15.4 kDa protein consisting of 137 amino acids. The protein has two domains, a C-
terminal DNA binding domain and an N-terminal self-association domain (Atlung and 
Ingmer, 1997). H-NS binds DNA in two distinct ways, by stiffening of DNA and by 
bridging of the double helix as shown in Figure 1.8 (Ayala et al., 2017; van der Valk et 
al., 2017). Transcription repression by H-NS requires cooperative binding to AT-rich 
DNA (Ayala et al., 2017). The formation of H-NS filaments across target promoter 
regions can exclude RNAP or trap the enzyme at promoters (Lucht et al., 1994; Fang and 
Rimsky, 2008). Formation of filaments is through determinants in the N-terminal 
dimerization domain. These regions of interaction give rise to sequential head-to-head 
and tail-to-tail interactions that enable H-NS to self-associate and bind across stretches of 




Like many regulatory proteins, H-NS controls the expression of genes through 
environmental signals such as pH, osmolarity and temperature (van der Valk et al., 2017). 
The precise mechanism of how each of these factors modulate H-NS activity is unclear 
(van der Valk et al., 2017). However, H-NS activity is subject to temperature control, 
with a higher affinity for DNA at 23oC- 25oC (Ono et al., 2005; Amit et al., 2003). As a 
result, it is believed that repression by H-NS can be relieved when bacteria encounter 
different temperatures and diverse environments (such as osmolarity and pH change), 
which act as cues for the expression of other activators that antagonise H-NS binding 














Schematic of the two main binding activities of H-NS. 
A) H-NS protein (blue circles) binds across stretches of AT-rich DNA (black solid line), 
forming filaments that occlude RNAP from binding to promoter DNA, therefore 
repressing the transcription of target genes. 
B) The H-NS protein can also bridge two segments of AT-rich DNA, forming a repression 
loop at promoter DNA.  
Figure 1.8. H-NS binding to DNA resulting in 
transcription repression 





A) Stiffening of DNA
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1.9 Vibrio cholerae 
Regulation of gene expression by environmental signals allows bacteria to compete 
effectively with other microbes within their host (Hibbing et al., 2010). The human gut is 
a classic example of a niche where enteric bacteria compete for nutrients and survival 
(Hibbing et al., 2010; Maynard et al., 2012). Some bacterial species can occupy the 
intestines as commensals, having evolved to decrease their pathogenicity and benefit from 
the gut’s environment. Other bacteria cause disease (Maynard et al., 2012). Vibrio 
cholerae is a Gram negative bacterium that causes the disease cholera (Kaper et al., 1995). 
V. cholerae is found throughout the world, particularly in coastal areas, where the 
bacterium is often associated with aquatic fauna (Colwell and Huq, 1994; Ayala et al., 
2017). Cholera is caused by the ingestion of food or water contaminated with V. cholerae 
(Kim et al., 2014). Every year, it is estimated that 4.3 million people are infected by V. 
cholerae, resulting in 142, 000 deaths (Ali et al., 2015; WHO, 2017).  
Since 1817, when the first recorded cholera pandemic began, more than 200 different 
serogroups of V. cholerae have been isolated from the environment (Beyhan et al., 2006). 
Of these, only two serogroups, the O139 serogroup and the O1 serogroup, have been the 
causative agents of epidemic and pandemic cholera (Matson et al., 2007). The most 
predominant serogroup, O1, exists as two biotypes; classical and El Tor. The El Tor 
biotype is most persistent in aquatic environments and now dominates (Matson et al., 




Classical and El Tor biotypes of V. cholerae O1 are genetically, phenotypically, and 
pathogenically different. The El Tor strain contains two horizontally transferred elements; 
Vibrio Seventh Pandemic islands one and two (VSP-I and VSP-II), which are absent in 
classical strains (Dziejman et al., 2002). The presence of an intact six gene repeat-in-toxin 
(RTX) cluster is also unique to El Tor strains compared to the truncated version found in 
classical strains (Safa et al., 2010). V. cholerae El Tor is better adapted for survival inside 
the human than the classical strain and has a longer duration of carriage after infection. 
This decreased virulence and longer carriage time enables the strain to be widely 
disseminated by the host to become endemic and thus outnumber the classical strain 
(Chaudhuri and Chatterjee, 2009; Mandal et al., 2011). Hence, the classical biotype has 




1.10 Transition from environmental reservoir to host 
The natural reservoir of V. cholerae is brackish waterways where the bacterium is often 
bound to the chitinous exoskeletons of zooplankton (Matson et al., 2007; Colwell and 
Huq, 1994; Ayala et al., 2017). Chitin, a polymer of N-acetylglucosamine (GlcNAc) is a 
widespread polysaccharide found in the cell wall of fungi and the exoskeletons of 
crustaceans (Markov et al., 2015). Furthermore, GlcNAc is a common modification of 
glycoproteins in the human intestinal epithelium (Meibom et al., 2004; Matson et al., 
2007). V. cholerae expresses a protein called GbpA which allows the bacterium to 
effectively bind to GlcNAc (Kirn et al., 2005). This attachment enables V. cholerae to 
survive in nutrient poor environments by utilising GlcNAc as a sole source of carbon and 
nitrogen (Meibom et al., 2005).  
Whilst in these environments, some V. cholerae enter into a viable but non culturable 
(VBNC) state or transition into the rugose phenotype often associated with biofilms 
(Morris, 2011). VBNC cells are metabolically dormant, but still capable of effective 
intestinal colonisation (Teschler et al., 2015; Almagro-Moreno et al., 2015). The 
formation of biofilms containing VBNC, and high doses of infective V. cholerae, are 
considerable contributors to the disease process (Hobley et al., 2015; Tamayo et al., 
2010).   
Ingestion of biofilms are one form in which V. cholerae infects its host, due to the 
concentration of cells present within them (Colwell et al., 2003). Once ingested the 
biofilm protects resident bacteria from stomach acids and enables them to reach the small 
intestine and establish infection (Zhu and Mekalanos, 2003). The intestinal environment 
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is associated with changes in pH, osmolarity and temperature. These signals cause 
changes in the bacterium’s transcriptome; expression of genes required for virulence and 
survival within the host increases (Silva and Benitez, 2016). Elucidating the exact 





1.11 The ToxR Regulon 
Expression of virulence determinants in V. cholerae involves a cascade of regulatory 
factors. The master regulator of this cascade is the 32 kDa membrane bound transcription 
factor, ToxR (Faruque et al., 1998). Expression of ToxR is under the control of 
environmental factors such as change in temperature, the presence of bile and osmolarity 
(Chaudhuri and Chatterjee, 2009). ToxS, another transmembrane protein, enhances the 
activity of ToxR and acts as a stabiliser or assembly point for ToxR monomers to form 
dimers. The major role of ToxR is to induce the expression of toxT in concert with a 
second activator called TcpP (Figure 1.9). Once expressed, ToxT activates the expression 
of genes encoding the major V. cholerae virulence factors and other colonisation genes 
(Kazi et al., 2016). 
 As well as activating genes encoding virulence factors via ToxT, ToxR directly regulates 
V. cholerae’s major outer membrane porins OmpU and OmpT (Kazi et al., 2016). 
Expression of these outer membrane porins is crucial for V. cholerae’s survival in the 
host; they enable the bacterium to resist antimicrobial peptides, bile and organic acids 
(Merrell et al., 2001; Mathur and Waldor, 2004). Recently, it has been shown that ToxR 
shares more than a third of its regulon with H-NS and antagonises H-NS repression to 





Figure 1.9. ToxR Regulon 
Schematic representation of the ToxR regulon. Environmental signals are the primary 
initiators of virulence factor expression. This leads to the expression of tcpPH. TcpPH 
interacts with ToxRS to activate transcription of toxT. ToxT (purple) activates 
transcription of other virulence factors and accessory toxins. ToxR also regulates the 
transcription of OmpU and OmpT, enabling the bacteria to tolerate resistance to 
antimicrobial peptides, bile, and tolerance to organic acids (Childers and Klose, 2007). 
Broken lines point to the protein encoded by the genes.  
ompU
ompT







1.12 ToxT structure and function 
ToxT is directly responsible for the activation of virulence gene expression in V. cholerae. 
The ToxT protein (32 kDa) is a member of the AraC family of transcriptional regulators. 
Hence, the protein is composed of two domains, an NTD of 164 aa and a 112 aa CTD 
(Withey and DiRita, 2006). The NTD functions as an environmental sensor and is 
involved in dimerization while the CTD binds DNA (Lowden et al., 2010). ToxT directly 
activates the expression of the major virulence genes and autoregulates its own expression 
from the tcp promoter (Figure 1.9) (Li et al., 2016). ToxT binds to DNA promoter regions 
upstream of target genes to activate transcription.  
Unlike regulatory proteins such as CRP, which binds to specific DNA motifs, tracts of 
four or more consecutive T/A nucleotides are the only common features found upstream 
of ToxT activated genes (Withey and DiRita, 2006). These sequences can occur 
singularly and form direct or inverted repeats. The motifs enable ToxT to bind DNA and 
positively regulate gene expression as a dimer or monomer, depending on the structure 
of the binding site (Lowden et al., 2010). The ToxT binding sites, or ‘toxboxes’, are all 
located upstream of the -35 promoter element (Bellair and Withey, 2008).  
This configuration makes all ToxT-dependent promoters class I promoters, suggesting an 
interaction with αCTD of RNAP (Weber et al., 2011). Genetic analysis using a rpoA 
truncation mutation, conducted by Hulbert and colleagues, showed that ToxT-dependent 




1.13 Overview of virulence factors 
V. cholerae produces an array of virulence and colonisation factors that exert toxic effects 
on the host and provide a growth and survival advantage to the pathogen. The V. cholerae 
genome consists of two circular chromosomes of 2.9 million and 1.07 million bps in 
length respectively (Heidelberg et al., 2000). Most of the genes required for growth, 
viability and virulence are found on chromosome I. In comparison, Chromosome II 
contains a larger number of hypothetical genes and genes of unknown function 




1.14 Cholera Toxin 
The cholera toxin (CT) is the best understood virulence factor produced by V. cholerae 
and is the cause of many clinical manifestations of cholera (Chaudhuri and Chatterjee, 
2009). The operon encoding the CT toxin, ctxAB, is found on chromosome I within the 
lysogenic bacteriophage CTXϕ (Chaudhuri and Chatterjee, 2009; Waldor and Mekalanos, 
1996). Horizontal acquisition of ctxAB distinguishes nontoxigenic and toxigenic strains 
of V. cholerae (Chaudhuri and Chatterjee, 2009). The CT holotoxin is made up of one A 
and five B subunits (Figure 1.10). The B subunit is 11.6 kDa, made up of 103 aa, and 
directs the holotoxin to the ganglioside GM1 receptors on the intestinal mucosa 
membrane. Translocation of the 27.2 kDa A subunit into the epithelial cell follows (Kaper 
et al., 1995). Upon translocation, the A subunit undergoes proteolytic cleavage into A1 
(195 aa) and A2 (45 aa) (Field, 1979). The target for the internalised CT toxin is adenylate 
cyclase. This enzyme mediates the conversion of ATP to cAMP and is one of the most 
important regulatory systems of eukaryotic cells (McDonough and Rodriguez, 2012). 
Regulation of adenylate cyclase is mediated by heterodimeric G proteins, which links 
surface receptors to effector proteins (Kaper et al., 1995). CT ADP-ribosylates G proteins, 
rendering adenylyl cyclase constitutively active (McDonough and Rodriguez, 2012). 
Increased intracellular levels of cAMP leads to alterations in cellular ion transport. This 
causes an increase in secretion of Cl- and decreased absorption of NaCl (Figure 1.10). 
The osmotic difference causes water to be drawn up from intravascular and extracellular 
spaces and this is rapidly lost as the characteristic ‘rice-water’ secretory diarrhoea 
















Figure 1.10. Pathway of Cholera Toxin 
Schematic of V. cholerae cholera toxin (CT) action. The CT holotoxin is composed of 
five B subunits (grey circles) and one A subunit. The ganglioside receptor (blue) is bound 
by the B subunit of the toxin, which enables the translocation of the A subunit into the 
cell. Once inside the cell, the A subunit undergoes proteolytic cleavage, that leads to a 
cascade of reactions such as the ribosylation of G proteins which ultimately leads to the 
constitutive expression of adenylate cyclase. Adenylate cyclase catalyses the production 
of cAMP which leads to alterations in the cellular transport membrane. This results in 













Lumen of small intestine
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1.15 Toxin co-regulated pilus  
The genes encoding the toxin co-regulated pilus (TCP) proteins are located in the 
horizontally acquired tcp operon (Figure 1.9). This operon locates to the vibrio 
pathogenicity island (VPI) on chromosome I (Waldor and Mekalanos, 1996; Chang et al., 
2017). The TCP is the receptor of the CTXϕ bacteriophage that encodes CT. Thus, the 
presence of TCP is a vital prerequisite that enables benign non-toxigenic strains of V. 
cholerae to become pathogenic (Chang et al., 2017). TCP is co-ordinately expressed with 
CT and is an essential virulence factor for V. cholerae. In 1988, Herrington et al. (1988) 
showed that TCP was one of the main colonisation factors that contributed to human 
disease (Herrington et al., 1988; Kaper et al., 1995). In V. cholerae, TCP are self-
aggregating type IV pili made up of TcpA subunit polymers (Chang et al., 2017). The pili 
enable motility, and the formation of microcolonies and biofilms (Taylor et al., 1987; 
Kirn et al., 2000). Formation of microcolonies protects the bacterium from the host’s 
immune response and locally concentrates the secreted CT toxin (Taylor et al., 1987). 




1.16 Multifunctional-autoprocessing repeats-in-toxin toxin  
The V. cholerae multifunctional-autoprocessing repeats-in-toxin (MARTX or 
MARTXVc) toxin is one of the accessory toxins of V. cholerae. The toxin and toxin export 
machinery are encoded by divergently transcribed rtxHCA and rtxBDE genes 
respectively. The MARTXVc toxin belongs to a superfamily of RTX (repeats-in-toxin) 
toxins that contain repeated GD-rich Ca2+ binding motifs (Lin et al., 1999; Kudryashova 
et al., 2014). V. cholerae exports MARTXVc via an atypical type one secretion system 
made up of transport ATPases (rtxB, rtxE), a linker protein (rtxD) and TolC (Boardman 
and Fullner Satchell, 2004). The toxin, encoded by rtxA, functions by promoting intestinal 
colonisation and evasion of host immune response (Olivier et al., 2007; Queen and 
Satchell, 2013). MARTXVc is a large 4545 aa toxin that causes the cross-linking of actin 
molecules and works with the pore-forming haemolysin and CT to avoid neutrophil 
clearance (Ma et al., 2009; Queen and Satchell, 2013; Sheahan et al., 2004). The toxin 
carries three main effector domains; actin cross-linking domain (ACD), the Rho 
inactivation domain (RID) and cysteine protease domain (CPD) and an alpha/beta 
hydrolase effector all linked by four unstructured regions (J.F, 2011). The N and C 
terminal domains of the toxin contain glycine rich repeats that are proposed to function 
as transmembrane pores for the translocation of the toxin (J.F, 2011). Once in the cytosol, 
the translocated CPD is activated by the small molecule inositol hexakisphosphate 
(InsP6). InsP6, is present in the eukaryotic cytosol at high concentrations but is absent from 
bacteria (Satchell, 2015). Once activated, the CPD can autoprocess the rest of the 
holotoxin at the unstructured regions between the effector domains. These effector 
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domains are then released into the cytosol where they proceed to induce cytotoxic and 






Schematic of MARTXVc toxin pathway. A) MARTXVc is made up of glycine rich repeats 
(GRR) (pink) which form the translocation domain, and the three main effector domains; 
actin crosslinking domain (yellow), rho-inactivating domain (blue), alpha beta hydrolase 
(purple) and cysteine protease domain (green). B) Once in the cytosol, the CPD is 
activated by InsP6 (red). CPD proteolytically activates the rest of the effector domains 
enabling them to carry out cytotoxic and cytopathic effects on the cell (Satchell, 2015).  
A) MARTXVc












B) Activation of toxin
RID
α/β
Figure 1.11. MARTXVc toxin pathway 
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1.17 Animal models for Cholera disease and colonisation 
Since the discovery of V. cholerae, there have been numerus attempts to generate the 
‘perfect infection model’ to study the disease. These models have ranged from the use of 
white mice by Roux in 1883, dogs by Nicati and Rietsch in 1884 and again by Carpenter 
and colleagues in 1966 and guinea pigs by Pfeiffer in 1894 (Carpenter et al., 1968; 
Pullitzer, 1959). However, the results generated by such models are erratic and seldom 
display the same disease characteristics as those seen in humans (Aziz et al., 1968). One 
reason for lack of reproducible results is that normal adult mammals, except humans, are 
not colonised by the bacterium (Klose, 2000). As a result, animals must be surgically 
altered to allow colonisation of their intestines. This is invasive and requires extensive 
surgical manipulation (Klose, 2000).  
An alternative model is the adult rabbit ileal loop, developed in 1953 by De and Chatterje 
(De and Chatterje, 1953). However, this again requires surgical intervention. More 
recently, work has shown that, V. cholerae can efficiently colonise the intestines of the 
suckling rabbit and mouse due to their naïve host defences (Richardson, 1994). These 
models do yield consistent results and are, to date, the most widely used models to study 
V. cholerae (Ritchie et al., 2010).  
However, despite their extensive use, no pathogenesis is evident in the infant mouse and 
the pathogenesis seen in the rabbit model does not strongly resemble that seen in humans 
(Runft et al., 2014). Due to limitations of mammalian models, the use of non-mammalian 
models has increased. These models include Drosophila melanogaster and the zebrafish, 
Danio rerio (Blow et al., 2005; Engeszer et al., 2007; Perez-Soto et al., 2017). Fish are 
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suggested to be a suitable model due to widespread intestinal colonisation of various 
species with V. cholerae (Senderovich et al., 2010). Specifically, the zebrafish’s natural 
habitat overlaps areas where cholera is endemic, suggesting a natural association between 




1.18 Vibrio cholerae CRP 
The V. cholerae CRP (VcCRP) protein shares 95% sequence identity with E. coli CRP 
(Figure 1.12) (Skorupski and Taylor, 1997b). Like E. coli CRP, VcCRP is dimeric and, 
when bound by its effector molecule cAMP, can regulate gene transcription from target 
promoters (Chattopadhyay and Parrack, 2006). VcCRP plays an important role in the 
regulation of V. cholerae virulence and pathogenesis (Chattopadhyay and Parrack, 2006). 
For example, CRP can reduce virulence through the activation the master quorum sensing 
regulator HapR and decreasing expression of CT and TCP (Skorupski and Taylor, 1997a).  
1.19 Deciphering transcription regulons in bacteria 
In recent years, interest has grown in mapping all binding sites of transcription factors 
and characterising the effects of binding to sites at target promoters (Li et al., 2016; Carey 
et al., 2012; Bellair and Withey, 2008). Experimental strategies include chromatin 
immunoprecipitation (ChIP) and the use of bioinformatics (Carey et al., 2012). The ChIP 
technique can be coupled with deep sequencing (ChIP-seq) to identify the genome wide 
binding profiles of transcriptional regulators and other DNA binding proteins. In 2015, 
Haycocks et al. (2015) used this technique to identify CRP and H-NS as the triggers of 
enterotoxin gene expression in enterotoxigenic E. coli (ETEC). A similar experiment was 
conducted, by James Haycocks, to identify binding sites of CRP and σ70 across both 





Figure 1.12. Amino acid sequence alignment of E. coli and V. cholerae CRP 
Sequence alignment of E. coli and V. cholerae CRP. The black letters show regions of 
identity and the red letters shows regions of disparity between the two sequences. Each 





















Figure 1.13. CRP and RNAP σ70 binding across V. cholerae genome 
Plots show the genome wide binding of CRP and RNAP σ70 for the two N16961 
chromosomes. The experiment was conducted on V. cholerae N16961 grown to mid-log 
phase at 200 rpm in LB broth. In each plot, the black arrow points to the tick mark at the 
12 o’clock position representing the first base pair (bp) of the chromosome. In each plot, 
tracks 1 and 2 (black lines) show the position of genes, track 3 (blue) is the 70 binding 
















Proposed pathways to be 
characterised in this work
A. CRP and RNAP 70 binding across 
V. cholerae genome
B. CRP and RNAP 70 binding at 
selected targets
C. Tentative model for coupling quorum 
sensing and virulence by CRP
i. Quorum sensing gene targets

























1.20 Brief overview of ChIP-seq 
In a ChIP-seq experiment, the protein of interest is cross-linked to DNA by treating the 
cells with formaldehyde. Sonication shears the DNA, and an antibody specific to the 
target protein is used to immunoprecipitate protein-DNA complexes. The crosslinks 
formed between the DNA and target protein are reversed and the released DNA is 
sequenced to identify sequences bound by the protein (Park, 2009; Grainger and Busby, 




1.21 Overview and aims of this work 
As stated above, CRP is a global transcription factor and plays a major role in V. cholerae. 
For example, VcCRP regulates both CT and TCP gene transcription. VcCRP also 
mediates the resistance of some V. cholerae strains to multiple environmental 
bacteriophages (Zahid et al., 2015). However, excluding the unpublished ChIP-Seq 
analysis from our laboratory, only 7 VcCRP sites have been experimentally confirmed. 
Hence, it is likely that VcCRP regulates many key genes in V. cholerae but the regulation 
has not been identified.  
Given the two distinct habitats of V. cholerae, and the use of GlcNAc for survival in the 
aquatic environment and the host, I hypothesised that VcCRP may be important for 
regulation of V. cholerae genes during lifestyle transitions (Kirn et al., 2005). To 
investigate this, I used the unpublished binding profile of VcCRP and σ70 across the 
genome of V. cholerae El Tor N16961 (unpublished data). This provided a catalogue of 
VcCRP and σ70 binding sites. The aim of my work was to investigate one such site at the 
shared regulatory region of the MARTXVc toxin and transport system. I seek to determine 
and characterise by primer extension assays and DNAse I footprinting i) the VcCRP 
binding and transcription start site across the rtxBDE and rtxHCA regulatory region and 
ii) in using zebrafish assays, investigate the role played by VcCRP in the transition of V. 
cholerae from the environment to the host. 
Chapters 3 details the optimisation of the tools used to monitor gene expression in V. 
cholerae and chapters 4 and 5 contain results of the effect of VcCRP on the  rtxBDE and 












 2.1 Generic reagents and buffers  
All reagents were obtained from Bioline, Thermo Fisher Scientific, Sigma-Aldrich or 
VWR, unless otherwise stated. Solutions used in this work were made by dissolving or 
diluting components in deionised distilled water (ddH2O) and autoclaving at 121
oC at 5 
psi for 20 minutes. All radioactive nucleotides were obtained from MP Biochemicals. A 






• Phenol/ chloroform/ isoamyl alcohol pH 8 (25:24:1) 
Ethanol precipitation: 
• 100% (v/v) ethanol 
• 70% (v/v) ethanol 
• 3 M sodium acetate pH.5.2 
• 20 mg/ml glycogen 
Preparation of competent cells: 
• 100 mM calcium chloride (CaCl2) 
• 50 % (v/v) glycerol 
Conjugation of bacterial cells: 
• 0.9% (w/v) sodium chloride (NaCl)  
• 20 g/L (w/v) Luria Bertani (LB) broth, Miller 
Preparation of naturally competent cells (V. cholerae): 
• 25 mg shrimp chitin in 2 ml microcentrifuge tubes (autoclaved) 
• 0.7% (w/v) Instant Ocean (obtained from SwellUK aquarium systems) 




Denaturing sequencing gel and Polyacrylamide gel electrophoresis (PAGE) 
reagents: 
• 5x TBE (0.445 M Tris borate pH 8.3, 10 mM EDTA) diluted to 1X with ddH2O 
prior to use 
• Ammonium persulphate 
• TEMED (N,N,N′,N′-Tetramethylethylenediamine) 
• 30% (w/v) Acrylamide: 0.8% (w/v) bisacrylamide mix (Purchased from 
Geneflow) 
• Sequagel ureagel system (Purchased from Geneflow) 
 
Agarose gel electrophoresis: 
• 6X Loading dye (10 mM Tris pH 7.5, 1 mM EDTA, 20% (v/v) glycerol, 0.025% 
(v/v) bromophenol blue, 0.025% (v/v) xylene cyanol FF) 
• 5X TBE (0.445 M Tris borate pH 8.3, 10 mM Na2EDTA) diluted to 1X with 
ddH2O prior to use  





• 1% (w/v) Sodium deoxycholate 
• 100% (v/v) Toluene 
• 1 M sodium carbonate  
• Z-buffer (8.53 g Na2HPO4, 4.87 g NaH2PO4.2H2O 0.75 g KCl, 0.25 g MgSO4 per 
L of ddH2O)  
• 13 mM (8 mg/ml) 2-Nitrophenyl β-D-galactopyranoside (ONPG) made up to 100 
ml in Z-buffer 
• β-mercaptoethanol, 271 μl per 100 ml of Z-buffer before use 
In vitro transcription: 
• 10X Transcription (TNSC) buffer (400 mM Tris acetate pH 7.9, 10 mM, MgCl2, 
1 M KCl, 10 mM DTT) 
• STOP solution (97.5% (v/v) deionised formamide, 10 mM EDTA, 0.3% (v/v)) 
• Bromophenol Blue/ Xylene Cyanol FF 




Radiolabelling of DNA fragments: 
• Tris-EDTA (TE) buffer: 10 mM Tris-HCl, 1 mM EDTA (pH 8.0) 
• G-50 sephadex beads resuspended in 12% (v/v) TE 
• T4 polynucleotide kinase  
• T4 polynucleotide kinase 10x buffer 
• γ-32P-ATP  
M13 sequencing reactions: 
• 2 M Sodium hydroxide (NaOH) 
• Annealing buffer 10x (1 M Tris-HCl pH 7.5, 100 mM MgCl2, 160 mM DTT) 
• ‘A’ mix short (840 μM each of dCTP, dGTP, and dTTP, 14 μM ddATP, 93.5μM 
dATP, 40 mM Tris-HCl pH7.5, 50 mM NaCl) 
• Label mix ‘A’: 1.375 mM of dCTP, dGTP, and dTTP each, 333.5 mM NaCl 
• T7 polymerase (purchased from Promega) 
• T7 polymerase dilution buffer (25 mM Tris-HCl pH 7.5, 5 mM DTT, 100 μg/ml 
BSA, 5% (v/v) glycerol) 
• STOP solution (0.025% (v/v) bromophenol blue, 0.025% (v/v) xylene cyanol FF, 
10 mM EDTA pH 7.5, 97.5% (v/v) formamide) 






• 1X Hybridisation buffer (20 mM HEPES, 0.4 M NaCl, 80% (v/v) formamide) 
DEPC treated 
• 100% (v/v) ethanol 
• 70% (v/v) ethanol (diluted with DEPC-treated ddH2O) 
• 3 M Sodium acetate pH 5.2 
• 3 M Sodium acetate pH 7 
 
G+A ladder generation: 
• DNAse I blue (5 M urea, 20 mM NaOH, 1 mM EDTA, 0.025% (v/v) bromophenol 
blue, 0.025% (v/v) xylene cyanol FF) 
• 10 M Piperidine, diluted to 1 M with ddH2O before use 
• 100% (v/v) Formic acid 
DNAse I footprinting: 
• Recombinant DNAse I. Supplied by Roche. 
• DNAse I blue: 5 M urea, 20 mM NaOH, 1 mM EDTA, 0.025% (v/v) bromophenol 
blue, 0.025% (v/v) xylene cyanol FF. 
• 10X Transcription buffer (TNSC buffer): 400 mM Tris acetate pH 7.9, 10 mM 
• MgCl2, 1 M KCl, 10 mM DTT. 




• E3 media 50X 1 L: 14.6 g NaCl, 0.65 g KCl, 2.20 g CaCl2, 4.05 g MgSO4 and 
23.85 g HEPES adjusted to pH 7. Working concentration used was 1X diluted in 
ddH2O. 
• 1-phenyl 2-thiourea (PTU): 1 mg/ml dissolved in ddH2O, filter sterilised and 
stored at -20oC. The working concentration used was 0.02 mg/ml. 
• Tricaine: 40 mg/ml dissolved in ddH2O, filter sterilised and stored at -20oC. 
Concentration used for anaesthetisation was 4 mg/ml; and 40 mg/ml for 
euthinisation. 
• Methylene blue: 0.1% (v/v) in ddH2O, filter sterilised and stored at room 
temperature. Working concentration used was 0.03% (v/v) in E3 media. 
• X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside): Dissolved in 
dimethylformamide to obtain a stock of 40 mg/ml. The working concentration 
used was 40 μg/ml. 




 2.2 Media Preparation 
2.2.1 Solid Media:  
All solid media was made up to 1 L in ddH2O and sterilised by autoclaving or bringing 
to a boil. 
• Luria-Bertani (LB) Agar, Lennox (15 g/L Agar, 10 g/L Tryptone, 5 g/L Yeast 
Extract, 5 g/L NaCl): 35 g in 1 L of ddH2O and autoclaved 
• Luria-Bertani (LB) Agar, Miller (15 g/L Agar, 10 g/L Tryptone, 5 g/L Yeast 
Extract, 10 g/L NaCl): 35 g in 1 L of ddH2O and autoclaved 
• MacConkey Agar: 52 g in 1 L of ddH2O and autoclaved 
• Thiosulfate citrate bile salts sucrose (TCBS): 88 g in 1 L of ddH2O brought to a 
boil.  
2.2.2 Liquid Media:  
All liquid media was made up to 1 L in ddH2O and sterilised by autoclaving unless 
otherwise stated. 
• Luria-Bertani (LB) Broth, Lennox (10 g/L Tryptone, 5 g/L Yeast Extract, 5 g/L 
NaCl): 20 g in 1 L of ddH2O  
• Luria-Bertani (LB) Broth, Miller (10 g/L Tryptone, 5 g/L Yeast Extract, 10 g/L 
NaCl): 20 g in 1 L of ddH2O  
• M9 Minimal Salts 10X: 70 g Na2HPO4, 30 g KH2PO4, 5 g NaCl and 10 g NH4Cl 
in 1 L of ddH2O and adjusted to pH 7.4  
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• Minimal Media (MM) 100ml: 10 ml of 10X M9 minimal salts, 200 μl 1 M MgSO4 
(pre-autoclaved), 100 μl of 0.1 M CaCl2, 1.5 ml 20% (w/v) fructose and 500 μl 
20% (w/v) casamino acids. This solution was made up to 100 ml with autoclaved 
ddH2O.  
 
2.3 Antibiotics  
Stock solutions of antibiotics were prepared, filter sterilised and stored at -20oC. 
• Ampicillin: Dissolved in ddH2O to obtain a stock solution of 100 mg/ml. The 
working concentration used was 100 μg/ml.  
• Tetracycline: Dissolved in methanol to give a stock solution of 35 mg/ml. 
Working concentration used was either 5 μg/ml or 35 μg/ml.  
• Kanamycin: Made up in ddH2O to a stock solution of 50 mg/ml and the working 
concentration used was 50 μg/ml.  
• Streptomycin: Stock solution of 100 mg/ml in ddH2O. Working solution used was 
100 μg/ml. 
• Spectinomycin: Made up to a stock solution of 50 mg/ml in ddH2O to give a 
working solution of 50 μg/ml. 





2.4 Preparation of competent E. coli cells  
One millilitre of an overnight E. coli cell culture was used to inoculate 50 ml of LB broth. 
This was incubated at 37oC at 200 rpm until the culture reached an OD650 of 0.5-0.6 
(measured using a Jenway 6300 spectrophotometer). The cell culture was transferred into 
a 50 ml sterile Falcon tube and chilled on ice for 10 minutes. Cells were pelleted by 
centrifugation at 1,600 x g for 5 minutes at 4oC and then re-suspended in 25 ml ice cold 
sterile 100 mM CaCl2. Cells were incubated on ice for 20 minutes then pelleted by 
centrifugation at 1,600 x g for 5 minutes at 4oC. The cells were then re-suspended in 3.3 
ml ice cold 100 mM CaCl2. The suspension was left overnight on ice at 4
oC to maximise 
competency before being aliquoted into microfuge tubes containing 333 μl of ice cold 
50% glycerol to every ml of cells for storage at -80oC. Cells were thawed on ice before 
use.  
2.5 Transformation of bacterial cells  
One to five μl of plasmid DNA (or entire ligation reaction) was incubated on ice with 100 
μl of competent cells for 1 hour. Cells were then heat shocked at 42oC for 2 minutes 
before briefly returned on ice. Five hundred μl of LB broth was added to the cells and 
then incubated at 37oC for 45 minutes at 200 rpm to recover. Cells were then pelleted by 
centrifugation at 2,400 x g for 2 minutes. Cells were re-suspended in 100 μl of LB broth 




2.6 Standard PCR reactions  
PCR reactions were done in 50 μl volumes. Each reaction contained 1x reaction buffer, 
0.5 mM of each dNTP (ATP/GTP/CTP/TTP), 1 μl of template DNA and 2 μM each of 
forward and reverse oligonucleotide primers. Velocity DNA polymerase (Bioline) was 
used to catalyse the reaction. A typical PCR cycle was: 
 98oC for 1 minute (initial denaturation step)  
98oC for 30 seconds (denaturation step) 
55oC for 30 seconds (primer annealing) 
72oC for 35 seconds (elongation) 
72oC for 10 minutes (final elongation step)  
The primer annealing temperature varied according to the oligonucleotide length and 
sequence. Typically, the annealing temperature used was the Tm of the lower primer plus 
1oC. The elongation duration was calculated at 30 seconds per 1000 bp. PCR products 
were separated on 1% agarose gels pre-stained with ethidium bromide using a DNA 
ladder as a marker.  
  
Repeated for 35 cycles 
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2.7 Agarose gel electrophoresis 
Agarose gels (0.8% or 1% w/v) were prepared by dissolving 0.8 g or 1 g of agarose in 
100 ml of 1X TBE respectively. The suspension was microwaved on a high setting to 
dissolve the agarose. One percent (v/v) ethidium bromide was added to the cooled 
suspension prior to pouring the gel. Electrophoresis was done at 100 V in 1X TBE buffer 
to the required migration distance. 
 
2.8 Ligation of standard PCR products into plasmid vectors  
PCR products were purified using Qiagen PCR purification kit according to the 
manufacturer’s instructions. After clean up, PCR products were digested with appropriate 
restriction enzymes, purified, and then used for ligation reactions. Plasmid vectors used 
in the ligation reactions were first digested with appropriate restriction enzymes. Vectors 
were then treated with alkaline phosphatase to remove 5’ phosphate groups. All vectors 
were purified by gel extraction except for pRW50 and derivatives that were purified by 
phenol-chloroform extraction. Ligation reactions were done in 20 μl volumes containing 
approximately 50 ng plasmid vector, 150-200 ng of cleaned and restricted PCR product, 




2.9 DNA and RNA extraction using Qiagen maxiprep, miniprep, or 
RNeasy extraction kits 
DNA and RNA were extracted according to the manufacturer’s protocol (Qiagen). In the 
procedure, DNA is adsorbed to the silica column at high pH in high salt solution, 
impurities are removed through a series of washes and the nucleic acid is eluted with 
water. Large scale DNA extraction, such as that used for in vitro transcription and DNAse 
I footprinting template preparation, was done using the Qiagen maxiprep kit. The Qiagen 
miniprep kit was used for smaller scale extractions such as the isolation of plasmids and 
cloning vectors. The RNeasy kit was used to extract RNA for use in primer extension 
assays. 
2.10 Sequencing of plasmid constructs 
Sanger sequencing of plasmids or PCR fragments was done by the Functional Genomics 
and Proteomics Facility at the University of Birmingham. Sequencing reactions were 
submitted in a 10 μl total volume, comprising 1 μl 10 μM primer, and 2-3 μg and 200-




2.11 Transfer of plasmid DNA by conjugation  
Conjugation, specifically tri-parental mating, was used to transfer genetic material to V. 
cholerae from E. coli DH5α. Overnight cultures of the following were used for the 
conjugation. 
• V. cholerae grown in LB (Miller) broth with 100 μg/ml streptomycin. 
• DH5α (carrying the tra donor pRK2013 helper plasmid) grown in LB (Lennox) 
broth with 50 μg/ml of kanamycin.  
• V. cholerae or DH5α (carrying the plasmid to be transferred) grown in either LB 
(Lennox) or LB (Miller) broth with appropriate antibiotic. 
One ml of each overnight culture was aliquoted into correspondingly labelled 
microcentrifuge tubes and centrifuged at 17 000 x g for one minute. The cells were 
resuspended in 1 ml 0.9% (w/v) NaCl to wash out residual antibiotics. This wash step was 
repeated three times. After the third wash, each pellet was resuspended in 1 ml of LB 
broth. The contents of all three microcentrifuge tubes were combined in a 15 ml falcon 
tube and incubated at 37oC for at least 4 hours. The cells were vortexed to stop the transfer 
and pelleted by centrifugation at 3 500 x g for 5 minutes. The supernatant was discarded 
and cells were resuspended in 5 ml 0.9% (w/v) NaCl. One hundred μl of the resuspension 




2.12 Preparation of naturally competent V. cholerae cells 
A single colony of V. cholerae was cultured in 2 ml of LB (Miller) broth with 100 μg/ml 
streptomycin. The culture was grown to mid log phase (OD650 of 0.8-0.9) and 1 ml was 
transferred to a microcentrifuge tube. Cells were collected by centrifugation at 10 000 x 
g for one minute. The supernatant was discarded and the cells were resuspended in 1 ml 
of 0.7% (w/v) instant ocean aquarium salt. The cells were again collected by 
centrifugation at 10 000 x g for one minute and resuspended in 1 ml of 0.7% (w/v) instant 
ocean. Nine hundred microliters of 0.7% (w/v) instant ocean was added to three tubes 
containing shrimp chitin, labelled A, B and C.  One hundred microliters of resuspended 




2.13 Multiplexed Genome Editing by Natural Transformation PCR 
reactions  
 A schematic for Multiplexed Genome Editing by Natural Transformation (MuGENT) 
PCR, which generates DNA fragments used for transformation, is shown in Figure 2.1 
(Dalia et al., 2014b). The PCR is done in two stages. The first step generates two 
overlapping “arms” that are joined in the second step. PCR reactions for each “arm” were 
done in 50 μl volume reactions containing 5 X reaction buffer, 0.05 mM of each dNTP 
(ATP/GTP/CTP/TTP), 1 μl of template and 1.6 μM each of forward and reverse primer 
(Figure 2.1 top). Q5 high-fidelity DNA polymerase from New England Biolabs was used 
to catalyse the reaction. A PCR cycle of 98oC for 15 seconds; 98oC for 10 seconds; 65oC 
for 20 seconds; 72oC for 1 minute 30 seconds was used and repeated for a total of 30 
cycles and a final elongation step of 72oC for 5 minutes. The product was separated on 
0.8% agarose gel pre-stained with ethidium bromide, with a DNA ladder as a marker. The 






Figure 2.1. MuGENT PCR reaction 
Schematic of MuGENT PCR reaction. Two sets of primers (F1 R1; F2 R2) were used to 
amplify DNA ‘Arms’ upstream and downstream of the crp gene. Each “arm” was 
approximately 3kb long. Primers R1 and F2, listed in table 2.3 each contained inverted 
repeat sequences of each other to generate complementary ‘sticky overhangs’ in each arm 
(dashed lines). The overhangs were set to anneal in a splicing by overhang extension 
(SOE) PCR reaction for 10 cycles before outermost primers F1 and R2 were added to 
generate 6 kb fragments with the crp gene removed. 
  
PCR to generate two separate arms
Splicing by overhang extension PCR 
to anneal the two arms together
Addition of the two outer primers to 


































Prior to the second PCR reaction PCR “Arm” fragments were pooled and excess primers 
were removed using the Qiagen QIAquick PCR purification kit. Splicing by Overhang 
Extension (SOE) PCR reactions were done in 50 μl volumes containing 5 X reaction 
buffer, 0.05 mM of each dNTP (ATP/GTP/CTP/TTP), 2 μl of template (pooled product 
from MuGENT PCRs) (Figure 2.1). Q5 high-fidelity DNA polymerase from New 
England Biolabs was used to catalyse the reaction.  
 
SOE PCR cycle 
98oC for 10 seconds 
65oC for 20 seconds 
72oC for 1 minute 30 seconds 
24oC pause 
98oC for 10 seconds 
68oC for 20 seconds 
72oC for 3 minutes  
72oC for 5 minutes (final elongation) 
Repeated for 10 cycles 
Add 1.6 μM of forward and reverse outer primers  
Repeated for 25 cycles 
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The product was separated on 0.8% agarose gel pre-stained with ethidium bromide, with 
a DNA ladder as a marker. The correspondingly sized SOE PCR product was excised and 
purified using the Qiagen Gel extraction kit. 
 
2.14 Transformation of naturally competent Vibrio cholerae 
After 48 hours incubation on shrimp chitin, the transforming DNA (SOE PCR product) 
was added to tube B and an equal volume of PCR grade water was added to tube A to 
serve as a negative control. A selection marker, VC1807::Kan, was also added to tube B. 
The selection marker was generated by MuGENT and SOE PCR. It was designed to 
replace the VC1807 gene (encoding a frame-shifted transposase gene) with a kanamycin 
resistance cassette. The selection marker was also added to tube C to serve as a positive 
control. The tubes were gently inverted to mix in the DNA, ensuring that the chitin settled 
at the bottom of each tube. The tubes were incubated at 30oC for 24 hours (Figure 2.2). 
After incubation, the tubes were vortexed at maximum speed for one minute to disrupt 
the biofilms formed on the chitin. One ml of LB broth was added to each tube and the 
tubes were incubated at 37oC for a minimum of one hour. Serial dilutions were set up for 
each tube and 100 μl each of the dilutions 10-5, 10-6 and 10-7 were plated on LB (Miller) 














Schematic diagram of V. cholerae transformation. SOE PCR products, and DNA for the 
selection marker, were added to microcentrifuge tubes containing chitin flakes and V. 
cholerae cells.  The tubes were inverted to mix in the products and incubated for 24 hrs 
at 37oC. Following incubation, 1 ml of LB broth was added to each microcentrifuge tube, 
vortexed and incubated at 37oC for 1 hr. The tubes were then vortexed for 1 min and serial 
dilution of the contents of each tube was made and 100 μl of 10-5, 10-6 and 10-7 dilutions 
was plated on LB (Miller) agar plates containing the antibiotics Kan and Sm. The plates 
were incubated at 37oC overnight. 
Figure 2.2. Overview of transformation of V. cholerae with MuGENT PCR 
products 
Chitin flakes and Wild-type V. cholerae
Add 6kb Arm + VC1807::Kan DNA 




Add 1 ml of LB
Incubate at 37oC 
for 1hr
Vortex for 1 
minute
Serial dilutions
Plate on LB (Miller) agar with 50 μg/ml 
kanamycin and 100 μg/ml streptomycin




2.15 Multiplex allele-specific colony (MASC) PCR 
Multiplex allele-Specific Colony (MASC) was used to check transformants from 
MuGENT experiments (Wang and Church, 2011). A schematic of the process is shown 
in Figure 2.2A. Individual transformants were added directly to PCR tubes. Each PCR 
reaction tube contained 25 μl containing equal volumes of MyTaq Red mix (Bioline), 
0.025µM primers and ddH2O. PCR cycle of 98
oC for 15 seconds; 98oC for 10 seconds; 
55oC for 20 seconds; 72oC for 1 minute 30 seconds were used and repeated for a total of 
35 cycles and a final elongation step of 72oC for 5 minutes. The product was separated 





Panel A shows a schematic of MASC PCR. Following transformation with the MuGENT 
products, the colonies on the transformation plates were each screened for the mutation 
by colony PCR. MASC primers that anneal approximately 550 bp upstream and 
downstream of crp gene were used to generate PCR products. Panel B shows a 1% 
agarose gel pre-stained with ethidium bromide alongside a 1 kb DNA ladder. Colonies 
without the desired mutation generated a 1730 bp PCR product (wild type), whist colonies 
with the crp gene deleted generated a 1100 bp product (Δcrp). The negative control 
contained the PCR master mix and primers only.










































2.16 β-Galactosidase assay 
β-Galactosidase assays were done as previously described (Miller and Mekalanos, 1988). 
Overnight cultures were set up from fresh colonies, 100 μl of each overnight culture was 
used to sub-culture using fresh media in triplicate. Cultures were grown to OD650 0.8-1.0. 
Cells were lysed with two drops each of 100% toluene and 1% (w/v) sodium deoxycholate 
and then vortexed. Lysates were aerated at 37oC for 20 minutes. A reaction buffer 
containing 271 μl of β-mercaptoethanol and 13 mM (8 mg/ml) of 2-Nitrophenyl β-D-
galactopyranoside (ONPG) per 100 ml of Z-buffer was prepared. One hundred μl of lysate 
was transferred to test tubes and the experiment was started by adding 2.5 ml of the 
reaction buffer to each tube at timed intervals. The reaction was stopped after turning 
yellow with 1 ml of 1 M sodium carbonate. The OD420 of the reaction was measured and 
the activity in Miller units was calculated using the formula:  
Activity (Miller units) = 
1000 x 2.5 x A x 𝑂𝐷420







T= Time (mins) 
A= Final assay volume (3.6 ml) 
V= Volume of lysed culture used (0.1 ml). 
2.5= Conversion factor to convert OD650 into dry protein mass (mg) based on the 
assumption that OD650 of 10 is equivalent to 0.4 mg/ml bacterial dry mass. 
1000/4.5= Conversion factor to convert A420 into moles of O-nitrophenol, assuming 
1mole/ml O-nitrophenol has an absorption of 0.0045 at OD420. 
Data shown in the results is the mean activity from three independent replicates. 
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2.17 In vitro transcription assays 
Promoter DNA fragments flanked by EcoRI and HindIII restriction sites were cloned into 
plasmid pSR and used to transform JCB387 cells. The pSR plasmid was purified from 
transformants using Qiagen Maxiprep kit. Resulting DNA was used as template for in 
vitro transcription as previously described (Kolb et al., 1995). Using plasmid DNA (16 
μg ml-1) as template, reactions contained 5 μCi α-32P - UTP, 20 mM Tris pH 7.9, 5 mM 
MgCl2, 500 μM DTT, 50 mM KCl, 100 μg ml
-1 BSA, 200 μM each of ATP, GTP, CTP 
and 10 μM UTP in a volume of 20 µl. RNAP holoenzyme, overexpressed by James 
Haycocks, from E. coli or V. cholerae containing σ70 was added to the reaction before 
incubation at 37oC for 10 minutes. Reactions were stopped with 20 μl of ‘STOP’ solution 
containing formamide, 250 mM EDTA, 2.5% (v/v) bromophenol blue and 2.5% (v/v) 
xylene cyanol. Four μl of each reaction was analysed by a denaturing PAGE at 60 W for 
1 hr. After electrophoresis, the gel was dried and exposed to a Bio-Rad phosphorscreen 
overnight. The gel image was visualised using the Bio-Rad Molecular Imager FX® 




2.18 Radioactive end-labelling of DNA fragments 
DNA fragments used for DNAse I footprinting and generation of G+A ladders were 
excised from pSR plasmid maxipreps. The plasmid was first digested with HindIII and 
treated with calf alkaline phosphatase (CAP) to dephosphorlylate the 5’ end of the DNA. 
The DNA was then purified using phenol chloroform extraction with ethanol precipitation 
and digested for a second time with AatII. The resulting fragment was purified by gel 
extraction using the QIAquick Gel Extraction Kit (Qiagen). The fragment was 
radiolabelled using T4 polynucleotide kinase (PNK). Briefly, each reaction mix contained 
up to 50 pmol of DNA fragment, 5 μl 10X T4 PNK reaction buffer, 1 μl γ-32P-ATP (10 
μCi/ μl) and 2 μl of T4 PNK. The reaction had a final volume of 50 μl and was incubated 
for 30 minutes at 37oC. The enzyme was inactivated by transferring the reaction to a 65oC 
heat block for 20 minutes. Unincorporated nucleotides were removed by passing the 




2.19 M13 sequencing reactions for primer extension assay 
The T7 sequencing kit (USB) was used to make sequencing reactions for gel calibration. 
Ten μg of single-stranded M13mp18 phage DNA (supplied in kit) was diluted to a volume 
of 32 μl and incubated with 8 μl 2 M NaOH at room temperature for 10 minutes. Seven 
μl of 3 M sodium acetate (pH 4.8), 4 μl ddH2O and 120 μl 100% (v/v) ethanol was added 
and incubated at -80oC for 15 minutes. After incubation, the samples were centrifuged for 
15 minutes at 4oC at 17 000 x g. The supernatant was discarded and the pellet washed 
with ice-cold 70% (v/v) ethanol and centrifuged at 4oC for 10 minutes at 17 000 x g. The 
resulting pellet was vacuum dried and resuspended in 10 μl of ddH2O. Ten ρmol of 
undiluted stock of the universal primer and 2 μl of annealing buffer was added to the 
resuspension, thoroughly mixed, and incubated at 65oC for 5 minutes. The tube was 
transferred to a 37oC heat block for 10 minutes, then allowed to cool at room temperature 
for 5 minutes, before briefly centrifuged. Two point five μl of each of ‘A’ Mix-short, ‘C’ 
Mix-short, ‘G’ Mix-short, and ‘T’ Mix-short was transferred into four correspondingly 
labelled tubes. A dilution of 1: 5 containing 1 μl of T7 polymerase stock (8 units/μl) and 
4 μl of dilution buffer was prepared for the labelling step. Fourteen μl of the annealed 
template/primer mix was mixed with 3 μl labelling mix, 1 μl of α-32P-dATP (10 μCi/μl), 
and 2 μl of the diluted T7 polymerase mix and then incubated for 5 minutes at room 
temperature. In the meantime, the four tubes, ‘A’,’G’,’C’, and ‘T’ were warmed in a 37oC 
heat block for 1 minute. Four point five μl of the reaction was transferred into each of the 
four tubes ‘A’,’G’,’C’, and ‘T’, mixed by gently pipetting up and down and then 
incubated at 37oC for 5 minutes.  
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The reactions were stopped by mixing in 5 μl of ‘STOP’ solution and briefly centrifuged. 
The reaction is stored at -20oC and a volume of 3 μl is transferred onto a microcentrifuge 
tube and heated for 2 minutes at 75oC before use. Sequencing reactions were run on a 6% 




2.20 Primer extension assay 
RNA was purified from cells carrying plasmid pRW50T derivatives encoding the 
promoter of interest fused to lacZ. The experiment was done over two days. 
Day 1 
The D49724 primer, which anneals downstream of the HindIII site on pRW50T, was 
radiolabelled with γ-32P-ATP and T4 PNK as described above. One μl of the radiolabelled 
primer (100-400 nM) was mixed with 40 μg of purified RNA, 1/10 volume of 3M sodium 
acetate and 2.5 volumes of ice-cold 100% (v/v) ethanol. The sample was centrifuged at 
17 000 x g for 10 minutes at 4oC and the pellet washed with 70% (v/v) ethanol. The pellet 
was vacuum dried and resuspended in 30 μl 1X hybridisation buffer, thoroughly mixed, 
then incubated at 50oC for 5 minutes. The primer was annealed by incubating the sample 
at 75oC for 15 minutes immediately followed by 50oC for 3 hours. After incubation, 75 
μl of ice-cold (v/v) ethanol was added to the sample, mixed with the contents, and then 





After the incubation, the sample was pelleted and washed in 70% (v/v), then vacuum 
dried. The pellet was resuspended in 31 μl of DEPC treated ddH2O. Primer extension 
reactions were carried out in 50 μl reaction volumes containing the resuspended annealed 
primer 5X reverse transcriptase buffer, 1 mM DTT, 0.2 mM dNTPs, 0.6 μl RNasin 
(RNAse inhibitor obtained from Promega) and 2.5 μl AMV reverse transcriptase 
(Promega). Each reaction was incubated at 37oC for 1 hour then stopped by incubation at 
72oC for 10 minutes. After a brief centrifugation, residual RNA was degraded by the 
addition of 1 μl 10 mg/ml RNase A and an incubation at 37oC for 30 minutes. The DNA 
was precipitated using 6.7 μl 3 M ammonium acetate and 125 μl 100% (v/v) ethanol and 
incubated at -80oC for 30 minutes. The reaction was pelleted, washed, vacuum dried and 
then resuspended in 4 μl STOP solution. Two μl of this primer extension reaction was 




2.21 GA ladder 
The G+A ladders used to calibrate the DNAse I sequencing gels were generated by 
Maxam-Gilbert sequencing. Each ladder was derived from the promoter fragment used 
in the DNAse I footprinting experiment. Reaction tubes contained 12 μl of 
end-radiolabelled DNA fragment (4 μl of DNA fragment diluted in 8 μl of ddH2O) mixed 
with 50 μl formic acid and incubated at room temperature for 2.5 minutes. The reaction 
was stopped with a solution containing 200 μl 0.3 M sodium acetate, 1 μl (20mg/ml) 
glycogen and 700 μl ice-cold 100% ethanol (v/v). The DNA fragment was precipitated by 
incubating the reaction tubes at -80oC for 20 minutes. The tubes were then centrifuged at 
17 000 x g for 15 minutes at 4oC. Supernatant was discarded and the resulting pellet 
washed three times with 70% ice-cold ethanol (v/v). After the third wash, the pellet was 
vacuum dried then resuspended in 200 μl 1 M piperidine and incubated for 30 minutes at 
90oC. The reaction was stopped with a solution containing 1 μl glycogen, 300 μl ice-cold 
100% ethanol (v/v) and 10 μl 3 M sodium acetate and precipitated by incubation at -80oC 
for 20 minutes. The DNA was pelleted by centrifugation at 17 000 x g for 15 minutes and 
washed twice with 70% ice-cold ethanol (v/v). The DNA pellet was vacuum dried and 




2.22 DNAse I footprinting  
Reactions contained approximately 10-40 μg of radiolabelled DNA with 12.5 μg/ml 
Herring sperm DNA to act as a nonspecific competitor. Purified V. cholerae CRP was 
diluted in a buffer containing 0.2 mM cAMP before being incubated with the DNA mix, 
to a total volume of 20 μl, at 37oC for 10 minutes. To each reaction, 3 μl of DNAseI was 
added for 1 minute before the reactions were terminated with 200 μl ‘STOP’ solution.  
The DNA was extracted from reactions using phenol-chloroform and ethanol 
precipitation. Purified DNA was resuspended in 4 μl of DNAse I blue. Prior to gel 
loading, the reactions and G+A ladder were heated to 90oC for 2 minutes. Gels were 6 % 
denaturing PAGE and electrophoresis was done at 60 W. Footprints were visualised by 
exposing the dried gel to a Bio-Rad phosphorscreen overnight. The gel image was 
visualised using the Bio-Rad Molecular Imager FX® system and analysed using Quantity 
One software. 
2.23 Denaturing PAGE gel 
Six% (w/v) denaturing PAGE was prepared by mixing using 80 ml of Sequagel 6 
monomer concentrate and 20 ml Sequagel complete reagents (National Diagnostics) in a 
beaker. Eight hundred μl freshly prepared   10% (w/v) APS (ammonium persulphate) and 
40 μl of TEMED (N,N,N′,N′-Tetramethylethylenediamine) was added to the solution to 
polymerise the reaction. The gel was cast into two glass cassettes and allowed to set for 
1-2 hrs. Once set, the gel was mounted in the running apparatus and pre-run at 60 W for 
30 minutes before the samples were loaded. 
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2.24 Bacterial strains and plasmid vectors  
The bacterial strains and plasmid vectors used in this work are listed in tables 2.1 and 2.2 
respectively. The E. coli strain JCB387, a highly competent strain, was used for general 
DNA manipulation and for cloning new promoter fragments in plasmids pRW50T or 
pSR. The initial ChIP experiments were done with V. cholerae strain N16961 but all other 
work was done with V. cholerae E7946 to facilitate natural transformation. E. coli and V. 
cholerae strains were kept in 40% and 30% glycerol solutions respectively for long term 
storage. To obtain single colonies, the stock was steaked onto selective agar plates and 









Δ (lacIPOZY), φX74, galK, galU, strA, F-
, λ-, strA 
(Casadaban and Cohen, 
1980) 
M182 Δ crp M182 Δ crp39 (Busby et al., 1983) 
E. coli DH5α 
F– endA1, glnV44, thi-1, recA1, relA1, 
gyrA96, deoR, nupG, purB20, 




(Grant et al., 1990) 
 
E. coli DH5α 
(pRK2013) 
DH5α, KanR, oriColE1, RK2- Mob+ 
Tra+ 
(Taylor et al., 1993) 
E. coli 
JCB387 
ΔnirB Δlac, F-, λ- 
 
(Typas and Hengge, 
2006) 
V. cholerae El 
Tor N16961 
Wild-type Inaba El Tor, SmR, HapR- (Heidelberg et al., 2000) 
E7946 Wild 
type 
 SmR derivative of E7946, El Tor Ogawa  (Dalia et al., 2014b) 
E7946 Δcrp 
Derivative of E7946 WT, VC1807::Kan, 
Δ crp 
This work 
E7946 Δtcp Derivative of E7946 WT, Δ tcp 





Table 2.2. Plasmids used in this study 
Plasmids Genotype Source 
pRW50 
16.9 kb plasmid featuring EcoRI-
HindIII restriction sites upstream of 
lacZ,  TetR, RK2 origin 
(Lodge et al., 1992) 
pRW50T Derivative of pRW50, Tra+ This work 
pRK2013 KanR oriColE1 RK2-Mob+ RK2-Tra+ 
(Figurski and Helinski, 
1979) 
pSR 
2.6 kb plasmid featuring EcoRI-
HindIII restriction sites upstream of a 
λoop terminator site. A pBR322 
derived plasmid encoding AmpR, 
ColE1 origin 
(Kolb et al., 1995) 
pRWXT 
Derivative of PRW50T, xylE gene 
upstream of EcoRI restriction site 
This work 
pMW-GFP 
High copy number plasmid with GFP 
constitutively expressed from lac 
promoter, SpecR 








Primer Sequence 5'-3' 
 Primers used to generate promoter fragments 
rtxB F GGCTGCGAATTCATTCTAATTTAATGGTGCGGTATTCCC 
rtxB R GCCCGAAGCTTCACCGCTTGTTAACATGTTCA 





tolC F GGCTGCGAATTCTGCCGACTACCAAGTGATGGCT 
tolC R GCCCGAAGCTTCATCGGTCCTATTCCTGACGTG 
nudF F GGCTGCGAATTCCATCGGTCCTATTCCTGACGTG 
nudF R GCCCGAAGCTTCATTCGTACCTCCTATTGATGAAC 









acfA R GCCCGAAGCTTCATTTTTTACTCCTATTTTTACCTGTG 
rtxB.1 F GGCTGCGAATTCTTAATTTGTATCAAAATTGAC 
rtxB -11-12 F 
GGCTGCGAATTCTTAATTTGTATCAAAATTGACTACAAA
ATAGACTATTTCAACATTGGTCATACAACGCTGACG 








 Primers used for Sanger sequencing and amplification of 
fragments from plasmids 
pRW50 F GTTCTCGCAAGGACGAGAATTTC 
pRW50 R AATCTTCACGCTTGAGATAC 
pSR F GCATTTATCAGGGTTATTGTCTC 
pSR R CATCACCGAAACGCGCGAGG 






 Primers used to generate new strains and plasmids 
Arm 1 delta 
crp F1 
CGCCAAACCAAGATTAACACTG 





























pRWXT F GCCTTGAGTCCACGCTGGATCCCCGACGACGACATGGC 
pRWXT R GCCCGGAATTCGACAACATGAACTATGAAGAGG 
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 Primers used for primer extension 
Universal 





Text in bold indicates restriction sites. Bold and italicised text describe the application of 
the primers.  
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2.25 Zebrafish model  
To study host colonisation by V. cholerae we used the zebrafish larvae model. The larvae 
used in this study are of the wild type AB strain. 
2.26 Zebrafish embryo maintenance 
Adult fish were kept in a recirculating tank system at the  
 at a 14/10 hours light/dark cycle at a pH of 7.5 and 26 °C. Zebrafish 
care, breeding and experiments were performed in accordance with the Animal Scientific 
Procedures Act 1986, under Home Office Project License 40/3681 (University of 
Birmingham). Zebrafish embryos were harvested in petri dishes containing water from 
the fish system. About 50-60 embryos are transferred into individual 90 mm petri dishes 
containing 25 ml of 1X E3 media, 0.03% of methyl blue and 0.02 mg/ml PTU to inhibit 
melanisation. The embryos were incubated  under a 14h-10h light-dark cycle at 32 °C for 
5 days. The larvae were maintained by regularly changing the incubation media to 




2.27 Infection of zebrafish embryos  
On day 3, single colonies of V. cholerae are used to inoculate universals containing 5 ml 
of minimal media. These were incubated at 37oC, shaking at 200 rpm overnight. On day 
4, 1 ml of the overnight culture was sub-cultured into new tubes containing 5 ml of 
minimal media. This culture was incubated at 37oC, and shaken at 200 rpm, until mid-log 
phase. The culture was then transferred into 5 ml falcon tubes and pelleted by 
centrifugation at 4 500 x g for 5 minutes. Cells were resuspended in 5 ml of 1X E3 buffer 
and washed three times to remove any residual antibiotics. After washing, cells were 
resuspended in 5 ml of 1X E3 and 107 cells/ml were transferred into each well of a 24 
well cell culture plate. For each infection strain, triplicate wells were set up and five larvae 
were transferred into each well. Prior to addition, the larvae stored in the petri dish, were 
sedated by adding tricaine to a final concentration of 4 mg/ml. The plates were incubated 




2.28 Determination of β-Galactosidase activity in V. cholerae colonised 
zebrafish larvae 
After overnight incubation the larvae were euthanised by adding Tricaine to a final 
concentration of 40 mg/ml. The media was agitated by pipetting up and down to remove 
any biofilms that may have formed at the bottom of the wells. The media was transferred 
into sterile bijous and the larvae into 1.5 ml dolphin microcentrifuge tubes. The larvae 
were homogenised using a hand held motorised homogeniser and 1X E3 was added to 
each tube to an equivalent volume to that of the transferred media.  
Two drops each of 100% toluene and 1% (w/v) sodium deoxycholate was added to each 
bijou and dolphin tube to lyse the cells. The β-galactosidase activity was carried out as 
described in section 2.16. 
2.29 Plating of Vibrio cholerae from media and larvae 
Following homogenisation and prior to lysing the cells, 0.5 μl of the homogenate and of 
E3 V. cholerae media was transferred into respective microcentrifuge tubes containing 1. 
5 ml of 1X E3 media. One hundred μl of this dilution was plated onto LB agar plates 
containing 5 μg/ml Tetracycline, 100 μg/ml streptomycin, 50 μg/ml 
spectinomycin and 40 μg/ml of x-gal. These were incubated at 37oC overnight and the 





Zebrafish embryos colonised with V. cholerae were imaged using the Zeiss Axio 
Observer.Z1 microscope with 10x objective for fluorescent channel and differential 
interference contrast (DIC) channel. The ImageJ image processing package (NIH) 
software was used to visualise the images and merge the fields. Visualization of embryos 
was done by immobilizing them in 0.4% low melting point agarose in E3 supplemented 
with 4 mg/mL Tricaine. Live Imaging was done at 32°C and humidity maintained at 80% 







Optimising tools to monitor 









Vibrio cholerae causes disease in humans and also colonises organisms within aquatic 
environments. Such organisms include fish, invertebrates and marine mammals (Grimes 
et al., 2009). Efficient colonisation depends on the bacterium’s ability to control gene 
expression in response to the environment (Reidl and Klose, 2002). This requires 
transcription factors. Historically, most of the tools used to study bacterial gene regulation 
have been derived from E. coli (DiRita et al., 1991). Hence, many V. cholerae studies 
have used genetic and biochemical materials derived from E. coli cells (Dalia et al., 
2014a; Duan and March, 2010; Dalia et al., 2015; Wu et al., 2015). For example, Yu and 
DiRita used E. coli to understand the role H-NS plays in control of V. cholerae genes 
regulated by ToxT.  Although these approaches have been useful, V. cholerae specific 
regulators like ToxR and ToxT (Yu and DiRita, 2002) are absent from E. coli. 
Furthermore, amino acid sequence differences are apparent when comparing the basal 
transcriptional apparatus of E. coli and V. cholerae. As detailed in chapter 1, the RNAP 
holoenzyme consists of α2, β, β’ and σ
70 subunits. The amino acid sequence of the subunits 
in E. coli and V. cholerae exhibit a 90%, 85%, 82% and 77% identity respectively 
(Heidelberg et al., 2000; Blattner et al., 1997). It is not known how these differences 
might impinge on basal activity or interactions with regulators. The aim of this chapter is 
to assess current tools used to study V. cholerae gene regulation. The data presented 
highlight the need to use endogenous V. cholerae enzymes. This chapter also reinforces 




3.2 Comparing E. coli and V. cholerae in vitro transcription systems 
The first goal was to understand differences in the basal properties of E. coli and V. 
cholerae RNA polymerase. Hence, native RNA polymerase core enzyme was purified 
from each organism, by James Haycocks, and holoenzyme was reconstituted with the 
cognate σ70 purified following overexpression. To compare the enzymes, we used a 
reconstituted in vitro transcription system. The first DNA template used for in vitro 
transcription was the rtxBDE regulatory region of V. cholerae (fully characterised in 
chapter 4). This DNA was cloned upstream of λoop terminator in pSR plasmid to generate 
the supercoiled DNA template. A schematic of the DNA template is shown in Figure 
3.1A. The rtxBDE regulatory region contains two CRP sites and two promoters (P1rtxB 
and P2rtxB). The CRP sites are involved in promoter repression (Chapter 4). The RNA 
products generated by each RNA polymerase from this DNA template were visualised by 
radiolabelling and electrophoresis (Figure 3.1B, C). Comparison between E. coli and V. 
cholerae RNAP revealed that both enzymes synthesised the same transcripts but with 
different efficiencies. Specifically, the V. cholerae RNA polymerase generated more 
RNA transcript from rtxBDE P2 compared to E. coli RNAP. Similarly, whilst CRP 
completely blocked transcription by V. cholerae RNAP at this regulatory region, E. coli 
polymerase was only partially hindered. Hence, for E. coli RNAP, the P2rtxB transcript 
was detected even in the presence of CRP. In a second experiment we compared the 
activity of the two RNA polymerases at a class I CRP activated promoter from E. coli 
strain H10407 (Haycocks et al., 2015). The promoter, PestA, controls expression of a 
heat-stable enterotoxin. Organisation of the regulatory region is shown in Figure 3.2A. 
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Figure 3.2B shows results of the assay with E. coli RNA polymerase. As expected, the 
PestA promoter was activated by CRP. Conversely, CRP was unable to activate 
transcription by V. cholerae RNA polymerase (Figure 3.2C). 
We conclude that there are subtle differences in the RNA polymerase from E. coli and V. 












Panel A shows a schematic of DNA template cloned upstream of the λoop transcriptional 
terminator in plasmid pSR showing both CRP sites (orange) and promoters. P1 (blue) and 
P2 (green) promoters with their transcript sizes are shown. Panels B and C show the 
transcripts generated for each rtxB promoter using E. coli RNA polymerase or V. cholerae 
RNA polymerase. E. coli polymerase generated a weaker intensity RNA transcript for P2 
(green) compared to V. cholerae polymerase. The addition of 1μM CRP (orange) and 10 
μM of its allosteric effector molecule, cAMP, completely blocks transcription from both 
rtxB promoters by V. cholerae RNA polymerase. Bacteria were grown in LB broth 
overnight at 200 rpm.  
  
Figure 3.1. In vitro multiround transcription comparing E. coli and V. cholerae 
RNA polymerase at rtxB promoter 
- -+ +
E. coli RNA 
Polymerase
















Panel A shows a schematic of DNA template cloned upstream of the λoop transcriptional 
terminator in plasmid pSR showing CRP sites (orange) and estA promoter (red). Panels 
B and C show the transcripts generated for estA promoter using E. coli RNA polymerase 
or V. cholerae RNA polymerase. The addition of CRP (orange) activates transcription 
from the estA promoter by E. coli polymerase as seen in the stronger intensity transcript 
in panel B. On the other hand, the addition of 1μM CRP (orange) and 10 μM cAMP 
blocks transcription from the estA promoter by V. cholerae RNA polymerase. Bacteria 
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Figure 3.2. In vitro transcription comparing E. coli and V. cholerae RNA 








3.3 Comparing gene expression in E. coli and V. cholerae cells 
3.3.1  Modification of an E. coli reporter plasmid for use with V. cholerae 
In the next set of experiments, we sought to compare transcription from a V. cholerae 
promoter in its cognate cellular environment and in the E. coli host. Initial experiments 
were problematic because the low copy number lacZ reporter plasmid pRW50 (Figure 
3.3A) was able to transform E. coli but not V. cholerae. This may be because V. cholerae 
secretes two extracellular nucleases, Dns and Xds (Blokesch and Schoolnik, 2008), that 
might hinder uptake of the large (16, 993 kb) pRW50 plasmid (Lodge et al., 1992). To 
avoid this problem, the pRW50 plasmid was modified. Specifically, the 517 bp cynX 
gene, which encodes a factor for cyanate transport not important for plasmid function, 
was replaced with an origin of transfer (oriT). The oriT sequence, derived from plasmid 
RK2, was amplified by PCR with the flanking traJ and traK regions as a 220 bp DNA 
fragment. This fragment contained BstEII and NheI restriction sites to enable ligation with 
pRW50. The resulting plasmid was named pRW50T (Figure 3.3B). Whilst the starting 
pRW50 plasmid was unable to transform chemically competent V. cholerae (Figure 3.4A) 
the pRW50T plasmid was successfully mobilised during conjugation and transferred to 
both E. coli and V. cholerae with similar efficiency with mean values of 257 and 215 




We also generated a derivative of pRW50T, called pRWXT, that encodes xylE upstream 
of the promoter cloning site (Figure 3.3C). The xylE sequence, derived from plasmid 
pRWX, was amplified by PCR to generate a 1.3 kb fragment containing BamHI and 
EcoRI restriction sites (El-Robh and Busby, 2002). The fragment was ligated into plasmid 
pRW50T that had been digested with EcoRI and BglII. The resulting plasmid allowed for 














 Schematic representation of pRW50 (A), pRW50T (B) and pRWXT (C) plasmids. To 
generate pRW50T, the cynX gene (panel A) was excised from pRW50 and replaced with 
oriT (purple in panel B). To generate pRWXT plasmid (C), the xylE gene (green in panel 
C) and λoop terminator were cloned upstream of the EcoRI and downstream of the BglII 
sites to generate a dual reporter plasmid. The tetracycline antibiotic resistance marker is 
shown in blue, lacZ gene is shown in yellow and the black lines represent the sites for the 
correspondingly labelled restriction enzymes. 








Panel A shows transformation efficiency of CaCl2 competent E. coli and CaCl2 competent 
V. cholerae by plasmid pRW50. Panel B shows conjugation frequencies observed for E. 
coli and V. cholerae using pRW50T. Error bars represent the standard deviation obtained 
from three independent replicates. 
  
A B 
Figure 3.4. Comparing transformation and conjugation in E. coli and V. cholerae 
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3.3.2  Comparison of promoter activity in V. cholerae and E. coli 
To determine if V. cholerae promoter activity differed in E. coli the regulatory DNA 
upstream of the V. cholerae tolC, rtxBDE, acfA and acfD genes was cloned in pRW50T. 
The acfA and acfD genes are accessory colonisation factors arranged in a similar 
configuration to the rtxBDE and rtxHCA genes. The derived plasmids were used to 
transform E. coli and V. cholerae by conjugation. The two strains were grown in LB broth 
at 200 rpm, to mid-log phase, and β-galactosidase activity was measured in lysates of the 
two strains (Figure 3.5). The data show that promoter activities can differ substantially 
between E. coli and V. cholerae. Specifically, the rtxBDE regulatory DNA stimulated no 
lacZ expression in V. cholerae whilst expression was detected in E. coli. Activity of the 
tolC regulatory region also differed between the two organisms. Conversely, the acfA and 
acfD promoters had similar activities in the two organisms. For the rtxBDE regulatory 
DNA the data are consistent with measurements of transcription in vitro shown in Figure 
3.2. Hence, CRP was unable to fully supress transcription driven by E. coli RNAP but 
transcription by the V. cholerae enzyme was blocked. We conclude that E. coli is a poor 








β-galactosidase activity measurements of regulatory promoter activity in E. coli and V. 
cholerae. The empty plasmid pRW50T was used as a control. Activity is measured in 
Miller Units. Cells were grown in LB broth at 200 rpm to mid-log phase. The error bars 
represent standard deviation for three biological replicates.   
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3.4 Using the zebrafish larvae model to study V. cholerae gene 
expression 
3.4.1 Outline of procedure 
The zebrafish has, for many years, provided an ideal model to study human infectious 
diseases (Rowe et al., 2014; Wang et al., 2013). Recently, work by several groups has 
demonstrated that the intestinal tracts of zebrafish are efficiently colonised by V. cholerae 
(Runft et al., 2014; Saslowsky et al., 2010). The zebrafish model is particularly useful 
because of the diverse microbiota of the fish. Furthermore, zebrafish share an 
environmental niche with V. cholerae (Runft et al., 2014; Austin, 2010; Senderovich et 
al., 2010; Gomez et al., 2013). We sought to exploit the pRW50T and pRWXT systems 
to monitor V. cholerae gene expression during colonisation of zebrafish larvae. A 
schematic representation of the procedure is shown in Figure 3.6. First, bacteria 
transformed with the appropriate plasmid derivative, encoding promoter::lacZ fusions, 
were used to inoculate E3 media containing zebrafish larvae (Figure 3.6 step 1). After 
colonisation, free swimming bacteria were recovered from the media. To isolate intestinal 
bacteria the larvae were washed and homogenised (Figure 3.6 step 2).  Cell numbers were 
determined by plating and gene expression levels determined using lacZ assays (Figure 




In step 1, zebrafish larvae (5 larvae per well) were transferred into 24 well flat bottom 
cell culture plates and infected with 106 cells per ml mid-log phase V. cholerae cells. They 
were incubated overnight at 32oC. Following incubation, the larvae were sedated, then 
separated from the media which contained the planktonic cells and washed once in sterile 
1X E3 media. The larvae were then resuspended in sterile 1X E3 media, euthanised and 
homogenised as shown in step 2. One hundred μl of a 1:3000 dilution of the homogenate 
and planktonic cells were each plated onto selective antibiotic plates and incubated at 
37oC overnight for colony counting (step 3). Two drops each of toluene and 1% (w/v) 
sodium deoxycholate was added to the rest of the homogenate and planktonic cells to lyse 
the bacterial cells.  The lysate was assayed using the β-galactosidase enzymatic assay to 
compare promoter activities between the two population. A yellow colour like the one 
shown in step 3, is indicative of enzyme activity. 
  
Figure 3.6. Schematic representation of zebrafish infection 
β-galactosidase activity





3.4.2 Impact of host colonisation on promoter activity 
Expression of lacZ from the V. cholerae tolC, rtxBDE, acfA and acfD promoters was 
determined using the system described above. Figure 3.7 shows that promoter activities 
differed between the planktonic and intestinal bacterial populations. Importantly, the 
changes observed were similar to those previously observed in rabbits and mice (Mandlik 
et al., 2011).  Of particular note is the 15-fold induction of rtxBDE promoter activity in 






Figure 3.7. Promoter activity of V. cholerae regulatory DNA in media vs host 
β-galactosidase activity measurements of V. cholerae regulatory DNA regions in 
planktonic cells compared to a host (larvae). Activities for tolC, acfA and acfD regulatory 
regions decreased in the host compared to planktonic cells. However, the activity for 
rtxBDE was substantially different in the two environments, with a 15 fold increase in 
activity from the larvae compared to the planktonic cells. Plasmid pRW50T with no DNA 
insert was used as a control. Activity is measured as arbitrary units. The error bars 






3.5 Zebrafish larvae model to study V. cholerae colonisation of the 
intestinal tract 
The plasmid pMW-GFP, with the green fluorescent protein constitutively expressed, was 
transferred into V. cholerae cells via conjugation. The resulting V. cholerae-GFP strain 
was used to inoculate larvae raised in E3 media to allow colonisation of the larval 
















The image the anatomy of a 4-day old zebrafish larvae. Five larvae were transferred into 
a 24 well culture plate with 106 cells per ml mid-log phase V. cholerae-GFP cells and 
incubated overnight. The following day, the larvae were separated and washed in sterile 
1X E3 media to remove bacterial that may be bound onto the surface of the larvae. Larvae 
were immobilised by mounting onto 0.4% low melting point agarose dissolved in 1X E3 
media and 160 μg/ml tricaine. Epifluorescence in merged bright-field and gfp images 
shows the colonisation of the intestinal tract with V. cholerae cells (magnified in the 
dashed rectangle). 




In this chapter, we describe simple and optimised protocols for characterising V. cholerae 
gene regulatory regions in vitro, in vivo, and in the context of a host. We demonstrate that 
these optimised approaches avoid artefacts associated with reliance on exogenous 
enzymes and E. coli genetic backgrounds. Furthermore, our data demonstrate the 
importance of considering host-microbe interactions in such studies. We suggest that the 
zebrafish larvae model for studying effects of host-microbe interactions on gene 
expression will be particularly useful. This system is better suited to large numbers of 







Characterisation of CRP 
binding at the rtxBDE and 








4.1 Introduction  
Cholera is transmitted to humans through the ingestion of contaminated food or water 
(Clemens et al., 2017). The bacterium has developed diverse and complex regulatory 
systems that enable it to modulate gene expression to adapt to the human intestines on 
exiting the various marine environments it colonises (Clemens et al., 2017; Chaudhuri 
and Chatterjee, 2009; Peterson, 2002). Upon entering the human host, the bacterium 
upregulates motility, produces enzymes that degrade mucin and penetrate the mucus layer 
of the intestinal epithilium (Almagro-Moreno et al., 2015). Once within the mucus layer, 
V. cholerae produces TCP and accessory colonisation factors (ACF) that enable 
adherence to the epithelial surface of the small intestine. Hence, colonisation is 
established (Peterson, 2002). Ultimately, disease results from the production of factors 
including CTX, repeats in toxin (RTX) and haemolysin (HlyA) (Clemens et al., 2017; 
Chaudhuri and Chatterjee, 2009).  Transcription factors including ToxT, ToxR, VpsT, 
AphA, AphB and VcCRP are involved in regulating genes during host colonisation 
(Peterson, 2002; Nielsen et al., 2010). As mentioned above, VcCRP binds DNA in 
response to the intracellular availability of cAMP to control genes involved in 
metabolism. In V. cholerae, VcCRP is also known to influence the ToxR regulon by 
directly inhibiting tcpP expression (Skorupski and Taylor, 1997a; Peterson, 2002).  
However, gene regulation by VcCRP during colonisation of a host intestinal tract by V. 
cholerae has never been studied (Liang et al., 2007). Previous work by our group, 
(unpublished data) used ChIP-seq to map the distribution of VcCRP across the V. 
cholerae genome. The data show substantial overlap between VcCRP binding and the 
ToxR regulon. Furthermore, these data suggest that VcCRP controls additional virulence 
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factors not regulated by ToxR. This chapter focuses on one such target, the genes 
encoding RTX and its transport system. Figure 4.1A shows ChIP-Seq data for VcCRP 
and σ70 at this locus. The sequence of the regulatory region is shown in Figure 4.1B. In 
this chapter, the precise VcCRP binding sites are identified and their role characterised. 
VcCRP is shown to be essential for specific induction of rtxBDE gene expression during 
intestinal colonisation. Examination of additional VcCRP target genes reveals similar 
effects at these targets. 
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4.2 Characterisation of VcCRP binding in the rtx locus 
The sequence of the rtxBDE /rtxHCA intergenic region is shown in Figure 4.2B. Analysis 
of the sequence identified two putative VcCRP sites named CRP1 and CRP2. These are 
underlined in the figure with each half of the CRP site shown in orange. The centre of the 
ChIP-seq binding peak for VcCRP is denoted by the asterisk above the sequence and 
aligns with the CRP2 site. To confirm binding, purified VcCRP was used in DNAse I 
footprinting assays with a DNA fragment derived from the intergenic region (Figure 4.1). 
A Maxam/Gilbert GA sequencing ladder was used to calibrate the footprinting gel (Figure 
4.2). Lane 1 shows the pattern of cleavage in the absence of VcCRP. Upon addition of 
VcCRP (lanes 2-7) a distinct change in the cleavage pattern was observed. The results 




Panel A shows ChIP-seq data for VcCRP (orange) and σ70 (blue) binding to the rtx locus. 
Genes are shown in mauve with the divergently transcribed rtxBDE and rtxHCA genes 
labelled. Panel B shows the sequence of the gene regulatory region between rtxBDE and 
rtxHCA. The centre of the VcCRP binding peak identified by ChIP-seq is indicated by an 
asterisk. Putative VcCRP sites (orange) are underlined and labelled. The inverted triangle 
shows the point the fragment was truncated to generate rtxB.1 fragment. Red letters and 
their correspondingly numbered positions denote the mutations that were made in the 
DNA fragment. Putative -10 and -35 elements are underlined and colour coded and 
transcription start sites with a correspondingly coloured arrow denoting the direction the 
gene is transcribed. 





















































The figure shows the results of a DNAseI footprinting experiment using the rtxBDE 
intergenic region and purified V. cholerae CRP and cAMP. The experiment was 
calibrated with a Maxam-Gilbert GA sequencing ladder and positions relative to the 
P2rtxB transcription start site (+1) are labelled. The triangle indicates addition of CRP 
and lanes 1-7 correspond to concentrations of 0, 0.175, 0.35, 0.7, 1.4, 2.1 and 2.8 μM 
respectively. Orange boxes show the positions of the predicted CRP binding sites. 
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4.3 Identification of the rtxBDE and rtxHCA transcription start sites 
To identify promoters in the rtxBDE-rtxHCA regulatory region, two approaches were 
used; mRNA primer extension assays and in vitro transcription assays. First, two DNA 
fragments, corresponding to each orientation, of the regulatory region, were generated. 
These were cloned upstream of the promoterless lacZ gene in pRW50T to create a lacZ 
fusion. The resulting plasmids were then used to transform E. coli DH5α strain and 
transferred to V. cholerae El Tor strain N16961 by conjugation. RNA from the conjugants 
was isolated and primer extension assays were done using an oligonucleotide that bound 
the lacZ mRNA of the plasmid encoded fusion. The results are shown in Figure 4.3. I was 
unable to derive any extension products for potential rtxBDE promoters for the conditions 
used. However, a single 201 nucleotide extension product was generated from rtxHCA 
transcripts. The corresponding transcription start site (TSS) aligns perfectly with a TSS 
identified by Papenfort et al (2015) and is labelled PrtxH in Figure 4.1B (Papenfort et al., 
2015). We reasoned that rtxBDE may be repressed in vivo since this would explain our 
failure to identify extension products. Hence, the rtxBDE intergenic region was cloned 
upstream of the oop terminator in pSR plasmid to create a template for in vitro 
transcription. The results of the experiment (Figure 4.4) show the production of three 

















The figure shows the primer extension products obtained from the rtxBDE and rtxHCA 
promoter fragments. Lanes 1-4 show arbitrary Sanger sequencing reactions for calibration 
of the gel and primer extension products for rtxB (lanes 5 and 6) and rtxH (lanes 7 and 8) 
promoter derived transcripts respectively. The cells were grown to mid-log phase at 200 
rpm in LB (lanes 5 and 7) or M9 minimal media (lanes 6 and 8) prior to RNA extraction. 
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The figure shows transcripts generated by V. cholerae RNA polymerase σ70 holoenzyme 
in the absence of CRP using the rtxBDE intergenic region, cloned in plasmid pSR, as a 
DNA template. The RNAI transcript is derived from the plasmid replication origin and 
serves as an internal control. The rtxB.1 derivative contains a truncated version of the 
rtxBDE intergenic region. Point mutations introduced to disrupt potential -10 hexamers 
with the corresponding nucleotide number are noted above the gel. Cells were grown 
overnight at 200 rpm in LB broth. 
  
Figure 4.4. Transcripts derived from rtxBDE intergenic region in vitro 






































To identify promoters of the in vitro transcription products, a series of rtxBDE fragment 
derivatives was generated. These included a truncation of the rtxBDE intergenic region 
that removed upstream sequences (truncation site is shown by an inverted triangle in 
Figure 4.1B). The truncated fragment was named rtxB.1 and versions of this truncated 
DNA template, with point mutations in all potential -10 hexamers, were also made 
(labelled red in Figure 4.B). Results of in vitro transcription assays show that truncation 
of the rtxBDE intergenic region did not prevent synthesis of the additional transcripts 
(Figure 4.4, lane 2). Hence, the transcripts originate downstream of the site marked by 
the inverted triangle in Figure 4.1B. The -55G-56G mutation (Figure 4.4, lane 3) did not 
prevent synthesis of additional transcripts. Hence, these mutations do not correspond to 
the site of an important element. However, the -29G-28G and -12G-11G mutations each 
prevent the production of a different transcript as seen in Figure 4.4, lanes 4 and 5. We 
conclude that these transcripts originate from the promoters labelled P1rtxB and P2rtxB 





4.4 Expression of the rtxBDE operon is repressed by CRP 
The presence of two CRP sites between rtxBDE and rtxHCA suggests a role in 
transcription regulation. However, neither CRP site is appropriately positioned to activate 
PrtxH, P1rtxB or P2rtxB; the sites are positions -126.5 and -148.5, -47.5 and -67.5 
and -63.5 -83.5 upstream of each transcription start site respectively. It has previously 
been shown that promoters with tandem upstream CRP sites can be subject to repression 
by CRP (Lee and Busby, 2012). To investigate this possibility, derivatives of the full 
length intergenic region where created in which the CRP sites were inactivated by point 
mutations shown in Figure 4.1B or altered to match the consensus for CRP binding. The 
various DNA fragments were cloned in either the rtxHCA or rtxBDE orientation upstream 
of lacZ in plasmid pRW50T. The constructs are shown schematically in Figures 4.5A and 
4.6A. in both cases mutated VcCRP sites are denoted “CRP-dis” and consensus VcCRP 
sites “CRP-cs”. The various constructs were used to transform V. cholerae strain N16961 
by conjugation. Promoter activity was measured by determining -galactosidase activity 
in lysates of the transformants. The data show that PrtxH activity is unaltered by any of 
the mutations (Figure 4.5B). Conversely, expression from the poorly active rtxBDE 
promoters increased when the VcCRP sites were inactivated (Figure 4.6B). These results 
are consistent with repression by VcCRP seen in previous in vitro transcription 
experiments (Chapter 3) and a further in vitro transcription assay testing different 
concentrations of VcCRP (Figure 4.7). Interestingly, Fong and Yildiz (2008) also made 
















Figure 4.5. Activity of PrtxH is not affected by VcCRP 
Panel A shows a schematic of each of the constructs whereby the VcCRP sites (orange) 
are either disrupted (shown with red X) or made consensus (green tick). Yellow arrow 
represents the lacZ gene. Panel B shows results of -galactosidase assays done using 
lysates of N16961 cells transformed with derivatives of the lacZ reporter plasmid, 
pRW50T, where lacZ expression is controlled by PrtxH and its derivatives. Empty 
pRW50T was used as a control. Assays were done using mid-log phase cultures grown 
in LB media. Activity is measured in Miller Units. The error bars represent standard 
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Figure 4.6. Expression of rtxBDE is repressed by VcCRP 
Panel A shows a schematic of each of the constructs whereby the VcCRP sites (orange) 
are either disrupted (shown with red X) or made consensus (green tick). Yellow arrow 
represents the lacZ gene. Panel B shows the results of a -galactosidase assays done using 
lysates of N16961 cells transformed with derivatives of the lacZ reporter plasmid, 
pRW50T, where lacZ expression is controlled by P1rtxB and P2rtxB and its derivatives. 
Empty pRW50T was used as a control. Assays were done using mid-log phase cultures 
grown in LB media. Activity is measured in Miller Units. The error bars represent 
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Lane 1      2 3 4 
CRP conc (μM) 0 0.175 0.35 0.7 
 
Figure 4.7. Transcripts derived from rtxBDE regulatory region are repressed by 
VcCRP 
The gel shows transcripts generated by V. cholerae RNA polymerase 70 holoenzyme and 
VcCRP with cAMP using the rtxBDE intergenic region, cloned in plasmid pSR, as a DNA 
template. The RNAI serves as an internal control. Increasing concentrations of VcCRP 
are depicted by the orange wedge and corresponding VcCRP concentrations are listed 







4.5 Activity of the rtxBDE promoters observed in the absence of 
VcCRP binding requires P1rtxB and P2rtxB 
Having established a role for VcCRP in repression of rtxBDE transcription a further 
experiment was designed to check that these effects required P1rtxB and P2rtxB. Hence, 
3 new promoter DNA fragments were generated with point mutations in either P1rtxB, 
P2rtxB or both (mutations are as shown in Figure 4.1B). These mutations were made in 
the context of the truncated rtxB.1 fragment that lacks the VcCRP binding site and hence 
has higher activity than the full length regulatory region (see first three bars in Figure 
4.8A). the constructs are illustrated schematically in Figure 4.8B.The rtxB.1 derivatives 
have been given the prefix P1, P2 or P1,P2 to indicate which promoter has been mutated. 
The various fragments were cloned upstream of lacZ in plasmid pRW50T and the 
resulting plasmids were used to transform V. cholerae strain N16961 by conjugation. 
Promoter activity was determined using lysates of the transformants. -galactosidase 
activity assays confirmed that increased gene expression due to deletion of the VcCRP 














  Panel A shows a schematic of each of the constructs whereby the VcCRP sites (orange) 
are either disrupted (shown with red X) or made consensus (green tick). Yellow arrow 
represents the lacZ gene. Panel B shows results of a -galactosidase assays done using 
lysates of N16961 cells transformed with derivatives of the lacZ reporter plasmid, 
pRW50T, where lacZ expression is controlled by PrtxB and its derivatives. Empty 
pRW50T was used as a control. Assays were done using mid-log phase cultures grown 
in LB media. Activity is measured in Miller Units. The error bars represent standard 
deviation for three biological replicates.  




























4.6     Effect of nutrient availability on rtxBDE promoter activity 
To further understand the role of VcCRP, P1rtxB and P2rtxB, we mutated the various 
DNA elements in the context of the full length regulatory DNA region. The mutations 
were as described in Figure 4.1B and the constructs are illustrated schematically in Figure 
4.9A. The ability of CRP to bind DNA in vivo is regulated by the ligand cAMP whose 
level is determined by nutrient availability (Chattopadhyay and Parrack, 2006). Hence, 
CRP binds target sites when cells are grown in M9 minimal medium but binding is 
reduced in LB broth and abolished upon addition of glucose (Haycocks et al., 2015). As 
such, repression of rtxBDE should be relieved in rich media. Hence, strains carrying the 
regulatory region derivatives were grown in M9 minimal media, LB broth or LB broth 
supplemented with 0.4% glucose.  As expected, compared to cells grown in M9 minimal 
media, -galactosidase activity due to the wild type regulatory region increased in LB 
broth and rose further upon addition of glucose (compare second bar for each culture 
condition in Figure 4.9). Consistent with our predictions, the effect of mutating the CRP 
sites was reduced in rich media. Furthermore, mutation of the promoter -10 elements 














Panel A shows a schematic of each of the derivatives, the wild type PrtxB promoter, PrtxB 
CRP-dis whereby the VcCRP site (orange) is disrupted (shown with red X) and P12rtxB 
CRP-dis whereby both the promoters (blue arrows) and VcCRP site (orange) are 
disrupted (disruption is depicted by red X). Yellow arrow represents the lacZ gene. Panel 
B shows results of a -galactosidase assays done using lysates of N16961 cells 
transformed with derivatives of the lacZ reporter plasmid, pRW50T, carrying different 
PrtxB derivatives. Cells were grown in M9 minimal media, LB or LB supplemented with 
0.4 % (v/v) glucose. Empty pRW50T was used as a control. Assays were done using mid-
















































log phase cultures. Activity is measured in Miller Units. The error bars represent standard 
deviation for three biological replicates.  
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4.7 The expression of the rtxBDE operon is derepressed in V. cholerae 
lacking the crp gene  
We next sought to generate a Δcrp mutant V. cholerae strain using the MuGENT 
technique (Dalia et al., 2014b). However, N16961, has a non-functional hapR gene, 
which enables  V. cholerae to be naturally transformed, and cannot be used in MuGENT 
experiments (Heidelberg et al., 2000; Joelsson et al., 2006). Hence, further work was 
done using V. cholerae El Tor E7946. The Δcrp derivative was generated and had the 
expected phenotype on MacConkey maltose agar (Figure 4.10). The primers used to 
construct the deletion are listed in table 2.3 (Chapter 2). The pRW50T plasmids 
containing the full length wild type rtxBDE regulatory region, and its derivatives, was 
transferred into both wild type E7946 and the Δcrp mutant strains by conjugation. 
Promoter activities were inferred by measuring β-galactosidase activity in lysates of the 
transformants. Data for the assays are shown in Figure 4.11. As expected, -galactosidase 
activity due to the wild type DNA fragment increased 6-fold in the crp mutant compared 
to the wildtype strain. A much smaller 2-fold increase in activity was observed for the 
DNA derivative with the VcCRP sites disrupted. This is likely due to residual VcCRP 
binding. As in previous experiments, mutation of the promoter -10 elements abolished 













The image shows the phenotypic difference between the Δcrp and E7946 strain when 
grown on MacConkey maltose agar. VcCRP is required for the expression of the mal 
gene in V. cholerae. Loss of the crp gene prevents the expression of maltase and the 
metabolism of maltose. As a result, maltose is not fermented and there is no pH change 
in the agar giving rise to pale colonies compared to the wild type.  
Figure 4.10. Image of wildtype V. cholerae growing alongside Δcrp on solid 















Panel A shows a schematic of each of the derivatives, the wild type PrtxB promoter, PrtxB 
CRP-dis whereby the CRP site (orange) is disrupted (shown with red X) and P12rtxB 
CRP-dis whereby both the promoters (blue arrows) and CRP site (orange) are disrupted 
(disruption is depicted by red X). Yellow arrow represents the lacZ gene. Panel B shows 
a -galactosidase assays done using lysates of E7946 and Δcrp cells transformed with 
derivatives of the lacZ reporter plasmid, pRW50T, carrying different PrtxB derivatives. 






































Cells were grown in M9 minimal media to mid-log phase. Empty pRW50T was used as 
a control. Activity is measured in Miller Units. The error bars represent standard deviation 




4.8 Conclusions  
The aim of the work described in this chapter was to investigate the role of VcCRP at the 
regulatory region shared by the rtxBDE and rtxHCA operons. These sets of genes, 
encoding the RTX toxin and export machinery respectively, play an important role in V. 
cholerae pathogenicity (Olivier et al., 2007; Satchell, 2015). Using a combination of 
biochemical and genetic assays we were able to identify two binding sites for VcCRP 
within the regulatory DNA (Figure 4.2). We showed that CRP had no effect on rtxHCA 
transcription and that these genes appear to be constitutively expressed (Figure 4.5). 
Conversely, we conclude that rtxBDE is repressed by VcCRP and, that this repression is 
relieved in rich growth media (Figure 4.9). These findings are consistent with previous 
work by Boardman et al. (2007) who noted repression of rtxBDE in nutrient poor 
environments but were unaware of the role played by VcCRP. Similar observations were 
reported in RNA-seq experiments comparing the V. cholerae transcriptome in nutrient 
poor and rich media (Mandlik et al., 2011).  We argue that VcCRP mediates these effects 
directly, by binding sites upstream of the rtxBDE promoters, rather than indirectly by 
interfering with the activity of an undefined activator of rtxBDE. Consistent with this, 
VcCRP was able to repress both P1rtxB and P2rtxB in vitro in the absence of other protein 







Role of CRP during 






5.1 Introduction  
The notion that fish may be reservoirs of V. cholerae, and play role in dissemination, has 
been suggested by many groups (Senderovich et al., 2010; Halpern and Izhaki, 2017). 
For example, colonisation of certain fish species may have sustained epidemicity in India 
and serve as disease reservoirs in certain parts of Africa (Pandit C. G., 1951; Hounmanou 
et al., 2016). Indeed, a recent study found up to 87% of fish species were colonised by V. 
cholerae in certain localities (Senderovich et al., 2010). Since fish and humans have 
similar gut mucosa, it has been postulated that certain fish species are suitable models to 
study V. cholerae intestinal colonisation and infection (Gomez et al., 2013; Rowe et al., 
2014).  
As demonstrated by Runft et al. (2014), the zebrafish larvae model is particularly useful. 
Hence, bacteria are added to saltwater solutions in which larvae are free swimming and 
colonisation follows without intervention. Given that changes in nutrient availability are 
associated with host colonisation we examined the effects of colonisation on gene 
regulation by VcCRP. Hence, this chapter describes the role that VcCRP plays during 
colonisation of an aquatic host. I have focused on the rtxBDE regulatory region described 
in previous chapter. 
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5.2 CRP plays a vital role during colonisation of an aquatic host 
To crudely understand the importance of VcCRP during host colonisation, we generated 
a derivative of V. cholerae E7946 that expresses green fluorescent protein (GFP) encoded 
by plasmid pMW-GFP. This facilitates visualisation of the bacterium during colonisation. 
To study colonisation we used four-day old zebrafish larvae. Figure 5.1A shows a single 
larva with labelled anatomical features. Larvae were infected with 106 V. cholerae cells 
per ml and the infection was tracked by monitoring fluorescence. Infections due to the 
wild type strain are disseminated throughout the intestinal tract as shown in panel B of 
Figure 5.1. Conversely, infections caused by cells lacking CRP or TCP are limited to the 
anterior intestinal tract and fail to colonize the mid-intestine and posterior intestine as 
observed in panels B and C. Quantification of fluorescence from the microscopy images 
revealed a 3-fold reduction in fluorescence, across the entire intestinal tract, for the Δcrp 











The figure shows the anatomy (panel A) and representative fluorescent microscopy 
images of a 4-day old zebrafish larvae (panel B-D). Panels B, C and D show microscopy 
images of zebrafish larvae colonised with the indicated V. cholerae strain. All bacterial 
strains were transformed with plasmid pMW-GFP to express green fluorescent protein 
allowing their detection. Larvae were immobilised by mounting onto 0.4% low melting 
point agarose dissolved in 1X E3 media and 160 μg/ml tricaine. Epifluorescence shown 
(green) is representative of merged bright-field and gfp images to show the colonisation 
of the intestinal tract with V. cholerae cells. (ai: anterior intestine; mi: mid intestine; pi: 
posterior intestine). 













   
 
Figure 5.2. Average signal intensities of larvae infected with V. cholerae E7946 and 
derivatives 
The graph shows the average GFP signal intensities from microscopic images of V. 
cholerae E7946 and derivatives. Each bar represents the mean intensities from 20 
individual images condensed in a microscope. Signal intensities were determined using 
the ImageJ image processing package (NIH) software. Error bars represent the standard 





















To quantify virulence of the various strains, we monitored survival of the larvae during 
incubation with the bacteria (Figure 5.3). Zebrafish larvae were infected with undiluted 
culture (wildtype: 9.1 x 109 cells; derivatives: 5.4 x 109 cells), or dilutions containing 109, 
108, 107 or 106 V. cholerae cells. Briefly, overnight cultures of each strain were used to 
inoculate a culture and, once in mid-log phase, cells were recovered by centrifugation, 
washed in sterile 1x E3 media, and resuspended in E3 media. Ten larvae per well were 
incubated with each of the derivatives at varying dilutions and monitored hourly for 12 
hours post infection. Larvae were assessed for vital signs such as movement and 
appearance and each experiment was conducted with three independent replicates. All 
larvae infected with wild type V. cholerae were dead by the end of the time course for the 
undiluted, 109 and 108 conditions (black line). Conversely, infections caused by strains 
lacking CRP or TCP were not usually fatal. We conclude that, both CRP and TCP are 




Each graph shows Kaplan-Meier estimators of survival for zebrafish larvae infected with 
wildtype (solid black line), Δcrp (broken orange line) or ΔtcpA (broken blue line) V. 
cholerae E7946 strains. The different panels illustrate experiments with the 
correspondingly labelled V. cholerae concentration. A cell free negative control of E3 
media only is shown in the last panel (solid purple line). Larvae were assessed for vital 
signs (presence of movement and appearance) every 1 hour and percent survival plotted 
using Kaplan-Meier analysis (n=10 larvae per condition, over three independent 
experiments). Statistical significance was assessed using a Mantel-Cox test. 
Figure 5.3. Survival of zebrafish larvae following infection with V. cholerae strains 
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5.3 CRP mediates the induction of the rtxBDE operon during host 
colonisation  
In chapter 3 I showed that that transcription from the rtxBDE promoters was triggered 
during colonisation of the intestinal tract. I hypothesised that this induction might result 
from reduced VcCRP-dependent repression. To test this, zebrafish larvae were inoculated 
with either wild type or crp derivatives of V. cholerae carrying the wild type 
rtxBDE::lacZ fusion in plasmid pRW50T. After colonisation, larvae were separated from 
planktonic bacteria present in the media and washed in E3 media to remove any residual 
bacteria. The larvae were then sacrificed to release the intestinal bacteria. Levels of -
galactosidase expression were determined from lysates of the planktonic and larvae 
populations. The data obtained are shown in Figure 5.4. in wild type cells, low rtxBDE 
expression was measured for planktonic V. cholerae and rtxBDE expression increased 
substantially during colonisation of the larval intestinal tract (Figure 5.4A, open bar). As 
expected, this increase in expression required both P1rtxB and P2rtxB promoters (Figure 
5.4A). However, in Δcrp cells, expression of rtxBDE was uncoupled from host 
colonisation as high activity was measured in both planktonic and intestinal populations 
(Figure 5.4B). The differences observed are not due to the different colonisation 
properties of the crp strain as deregulation of rtxBDE occurs in planktonic populations 
and not within the larvae. Again, the measured activity required the P1rtxB and P2rtxB 




     
 
Figure 5.4. Expression of rtxBDE is induced by larvae colonisation 
The graphs show the result of a -galactosidase assay done using lysates of bacterial cells 
growing planktonically (filled bars) in E3 media or obtained from the zebrafish intestinal 
tract (open bars). Strains used for the infection are indicated above each panel. Panel A 
(blue) shows wildtype and panel B (orange) Δcrp strains. Each of the strains were 
transformed with pRW50T encoding the different derivatives of rtxBDE::lacZ fusions. 
Empty pRW50T was used as a control. Assays were done using mid-log phase cultures. 
Promoter activity is measured as arbitrary units. The error bars represent standard 














































5.4 CRP modulates the expression of many V. cholerae genes during 
host colonisation 
Logically, other VcCRP targeted promoters should also lose the ability to differentiate 
between aquatic environments and the host intestinal tract in the absence of VcCRP. To 
test this, four promoters were selected using our ChIP-seq data. The four promoters are 
organised as two pairs of divergently transcribed genes with a CRP site in the associated 
intergenic region like the rtx locus. The genes were tolC (encoding an outer membrane 
channel important for bile tolerance and export of the rtxA toxin), acfA (encoding 
accessory colonisation factor A), acfD (encoding accessory colonisation factor D) and 
nudF (encoding a pyrophosphatase) (Minato et al., 2011; Parsot and Mekalanos, 1992; 
Bessman et al., 1996).  
To confirm binding, purified VcCRP was used in DNAse I footprinting assays with DNA 
fragments derived from the tolC-nudF and acfA-acfD intergenic regions. The sequence 
of each intergenic region is shown below each gel in Figures 5.5B and 5.6B. 
Maxim/Gilbert GA sequencing ladders were used to calibrate the footprinting gels 
(Figure 5.5A and 5.6A) and numbering corresponds to the transcription start site (+1) 
relative to the promoter indicated as obtained from Papenfort et al., (Papenfort et al., 
2015). For both footprints lane 1 shows the pattern of DNAse I cleavage in the absence 
of VcCRP. Upon addition of CRP (lanes 2-8) a change in the cleavage pattern was 
observed. The results generated from the footprints are consistent with CRP binding to 




















Panel A shows the results of a DNAse I footprinting experiment using the tolC-nudF 
intergenic region and purified V. cholerae CRP and cAMP. The experiment was 
calibrated with a Maxam-Gilbert GA sequencing ladder and panel B shows positions of 
the tolC (blue) and nudF (green) transcription start sites (+1) as labelled. The triangle 
indicates addition of CRP and lanes 1-8 correspond to concentrations of 0, 0.175, 0.35, 
0.7, 1.4, 2.1 and 2.8 μM respectively. Orange box shows the position of the predicted 
VcCRP binding site, also labelled as orange underlined text in panel B.  









































Panel A shows the results of a DNAse I footprinting experiment using the acfA-acfD 
intergenic region and purified VcCRP and cAMP. The experiment was calibrated with a 
Maxam-Gilbert GA sequencing ladder and positions of the acfD (red) and acfA (purple) 
transcription start sites (+1) are labelled (panel B). The triangle indicates addition of 
VcCRP and lanes 1-8 correspond to concentrations of 0, 0.175, 0.35, 0.7, 1.4, 2.1 and 2.8 
μM respectively. Orange box shows the position of the predicted VcCRP binding site, 
also labelled as orange underlined text in panel B. 
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 To understand the regulatory effect of VcCRP during host colonisation the promoter 
regions were cloned upstream of lacZ in plasmid pRW50T. The plasmids were then used 
to transform V. cholerae E7946 and the Δcrp derivative. Zebrafish larvae were inoculated 
with either wild type or Δcrp derivatives of V. cholerae carrying the tolC, nudF, acfA or 
acfD::lacZ fusions in plasmid pRW50T. After infection, larvae were separated from 
planktonic bacteria and β-galactosidase activity was determined from the lysates of the 
planktonic and larvae populations (Figure 5.7).  
The data shows that in the wildtype strains, all the genes expressed were downregulated 
in intestinal compared to planktonic populations (Figure 5.7). However, when the 
experiment was repeated using Δcrp cells, expression of all genes was rendered 











The graphs show the result of -galactosidase assays done using lysates of bacterial cells 
growing planktonically (filled bars) in E3 media or obtained from the zebrafish intestinal 
tract (open bars). Strains used for the infection are indicated above each panel, with 
wildtype shown in panel A (blue) and Δcrp in panel B (orange). Each of the strains were 
transformed with pRW50T encoding the different derivatives of tolC; nudF, acfA or 
acfD::lacZ fusions. Empty pRW50T was used as a control. Assays were done using mid-
log phase cultures. Promoter activity is measured as arbitrary units. The error bars 
represent standard deviation for three biological replicates.  
Figure 5.7. Expression of other promoters downregulated by CRP in host 
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This chapter examines the role of VcCRP during colonisation of the zebrafish host. I 
focused on the rtxBDE regulatory region and showed that host specific induction of 
transcription is regulated by VcCRP in a zebrafish model (Figure 5.4). The data is 
consistent with repression of rtxBDE by VcCRP that is relieved within the intestinal tract 
and other nutrient rich environments as also seen in chapter 4. Previous transcriptome 
analysis led to speculation that VcCRP may modulate the expression of V. cholerae 
virulence factors in response to host colonisation (Mandlik et al., 2011; Papenfort et al., 
2015). Here,using the zebrafish larvae colonisation model, I was able to establish that, for 
all genes examined, differential expression in planktonic and intestinal populations 
required CRP (Figure 5.7).  
Previous host colonisation studies such as that done by Mandlik and colleagues support 
our model (Mandlik et al., 2011). Their work monitored global transcription in V. 
cholerae using RNA-seq and their data demonstrate induction of rtxBDE within the 
intestinal tracts of both mice and rabbits (Mandlik et al., 2011). As we see in Figure 5.7, 
other promoters also required CRP to respond to the intestinal environment. Hence, 













Regulation of gene expression allows bacteria to adapt to changes in nutrient availability, 
temperature, and pH. Gene expression can be regulated at any step from transcription to 
translation. However, the most common and cost effect is the control of transcription 
initiation.  
The focus of this work has been regulation of transcription initiation in V. cholerae in 
response to host colonisation. I have focused on the transcription factor VcCRP and 
demonstrate a role in the control of lifestyle switching by V. cholerae. The ability of V. 
cholerae to persist in environmental reservoirs, colonise the intestinal tract, and cause 
disease, requires careful co-ordination of gene expression. The mechanism through which 
V. cholerae achieves the ability to switch lifestyle remains unclear. Identifying the role 
of VcCRP in lifestyle switching will enable a better understanding of V. cholerae and 
how it has evolved to efficiently occupy different niches. 
Using ChIP-seq, biochemical assays and zebrafish studies, I was able to focus on the 
rtxBDE and rtxHCA regulatory region and provide a better understanding on the 
regulatory effect of VcCRP.  I optimised the protocols required to characterise specific 
V. cholerae genes in vitro, in vivo and in the context of a host. Having paid particularly 
close attention to genes encoding the RTX toxin and export machinery, I was able to show 
that the rtxBDE genes are transcribed from two promoters; P1rtxB and P2rtxB. The 
rtxHCA and rtxBDE genes encode the RTX toxin and toxin export machinery respectively 
(Satchell, 2015). The RTX toxin is known to contribute to pathogenesis by causing the 
depolymerisation and crosslinking of actin (Sheahan et al., 2004). This work also 
identified and characterised two VcCRP sites within the rtxBDE intergenic region and 
150 
 
showed that these sites repress gene transcription in nutrient poor environments. 
Furthermore, I detected repression of rtxBDE in M9 minimal media compared to LB 
broth. Previous work by Mandlik et al. (2011), monitoring global transcription in V. 
cholerae using RNA-seq, demonstrate induction of rtxBDE within the intestinal tracts of 
both mice and rabbits. The same study also detected repression of rtxBDE in M9 minimal 
media compared to LB broth (Mandlik et al., 2011). Similarly, Boardman et al. (2007) 
also noted repression of rtxBDE in nutrient poor environments. The data presented here, 
in chapters 4 and 5, is also consistent with repression of rtxBDE by VcCRP that is relieved 
within the intestinal tract and other nutrient rich environments. Given the location of the 
VcCRP sites in respect to promoters, I argue that VcCRP mediates these effects directly 
by binding sites upstream of the rtxBDE promoters, similarly shown in previous studies 
where tandem binding by E. coli CRP lead to repression (Lee and Busby, 2012). This 
de-repression of rtxBDE by VcCRP in nutrient rich environments suggests that the toxin 
is only exported when the bacteria encounters host cells.  This target or contact specific 
export of RTX toxin was observed in V. vulnificus, whereby the toxin kills the cell only 
after contact of the bacteria with host cells (Kim et al., 2008).  
Our work showed that VcCRP had no effect on the expression of the rtxHCA genes and 
we put forward a model that the toxin is constitutively expressed and only exported upon 
entry into nutrient rich environments such as a host. A hypothesis supported by our data. 
Boardman et al. (2007) also suggested constitutive expression of the toxin but showed 
that neither the toxin nor mRNA transcript was accumulated in the cytoplasm of the 
bacteria. Recent work by Papenfort et al. (2015) show that the rtxHCA region is regulated 
post transcriptionally by the regulatory RNA, VqmR. VqmR directly represses the 
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translation of rtx toxin transcripts, by binding to the mRNA transcripts in a quorum 
sensing dependent manner (Papenfort et al., 2015). 
 Previous transcriptome analysis by Liang et al. (2007) suggested that CRP may modulate 
the expression of other V. cholerae virulence factors in response to host colonisation. 
Here we have tested this prediction using the zebrafish larvae colonisation model, used 
by Runft et al. (2014), and show that apart from the rtxBDE and rtxHCA regulatory 
region, other genes, such as tolC and acfA/D, involved in V. cholerae pathogenicity were 
also targets for VcCRP. For all genes examined differential expression in planktonic and 
intestinal populations required CRP. Taken together, previous host colonisation studies 
support our model that VcCRP is integral to the regulatory network that controls 
V. cholerae lifestyle switching.  
Finally, it is of note that VcCRP regulates genes expression in response to the availability 
of glucose; this sugar is a major component of oral rehydration solutions at the forefront 
of cholera treatment. Hence, it may be possible to optimise such solutions to alter the 
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